@NP	Xenografts of expanded primate olfactory ensheathing glia support	1
@NP	Xenografts	1
@NP	expanded primate olfactory ensheathing glia support	15
@NP	transient behavioral recovery that is independent	67
@NP	transient behavioral recovery	67
@NP	serotonergic or corticospinal axonal regeneration	120
@NP	nude rats following spinal cord transection J.D.	173
@NP	nude rats	173
@NP	spinal cord transection J.D.	193
@NP	a , b , , L.	230
@NP	a , b ,	230
@NP	a	230
@NP	b	232
@NP	L.	237
@NP	Herrera b , I.	240
@NP	Herrera b	240
@NP	I.	251
@NP	Margitich b , M.	254
@NP	Margitich b	254
@NP	M.	267
@NP	Oliveria b , A.	270
@NP	Oliveria b	270
@NP	A.	282
@NP	Marcillo b , C.E.	285
@NP	Marcillo b	285
@NP	C.E.	297
@NP	Casas	302
@NP	a Department	310
@NP	Neurological Surgery , University of Miami , Miami , FL , USA b Miami Project	326
@NP	Neurological Surgery	326
@NP	University of Miami , Miami , FL , USA b Miami Project	348
@NP	University	348
@NP	Miami , Miami , FL , USA b Miami Project	362
@NP	Miami , Miami , FL	362
@NP	USA b Miami Project	380
@NP	Paralysis , University of Miami , Miami , FL	408
@NP	Paralysis	408
@NP	University of Miami , Miami , FL	419
@NP	University	419
@NP	Miami , Miami , FL	433
@NP	USA Abstract Transplantation	451
@NP	olfactory ensheathing glial cells -LRB- OEG -RRB-	484
@NP	olfactory ensheathing glial cells	484
@NP	OEG	519
@NP	the outcome	536
@NP	spinal cord injury	553
@NP	Proof-of-principle studies in primates	573
@NP	Proof-of-principle studies	573
@NP	primates	603
@NP	the feasibility and efficacy of using in vitro expanded OEG	630
@NP	the feasibility and efficacy	630
@NP	OEG	686
@NP	An intermediate step	708
@NP	the validation of rodent studies and human clinical trials	737
@NP	the validation	737
@NP	rodent studies and human clinical trials	755
@NP	rodent studies	755
@NP	human clinical trials	774
@NP	primate OEG -LRB- POEG -RRB- xenografts in immunotolerant rodents	817
@NP	primate OEG -LRB- POEG -RRB- xenografts	817
@NP	POEG	830
@NP	immunotolerant rodents	850
@NP	this study	877
@NP	the time course to generate purified POEG	888
@NP	POEG	925
@NP	their survival	955
@NP	effect on damaged axons of the corticospinal and serotonergic systems	971
@NP	effect	971
@NP	damaged axons of the corticospinal and serotonergic systems	981
@NP	damaged axons	981
@NP	the corticospinal and serotonergic systems	998
@NP	tissue sparing	1042
@NP	chronic locomotor recovery following transplantation	1062
@NP	chronic locomotor recovery	1062
@NP	transplantation	1099
@NP	Fiftyseven nude rats	1116
@NP	T9/10 spinal cord transection	1147
@NP	T9/10	1147
@NP	spinal cord transection	1153
@NP	Thirty-eight rats	1178
@NP	POEG	1205
@NP	19 controls	1211
@NP	cell medium	1242
@NP	10	1259
@NP	lentivirally-GFP-transfected POEG	1271
@NP	Histological evaluation	1306
@NP	6 weeks , 8 weeks , 14 weeks and 23 -- 24 weeks	1347
@NP	6 weeks	1347
@NP	8 weeks	1356
@NP	14 weeks	1365
@NP	23 -- 24 weeks	1378
@NP	23	1378
@NP	24 weeks	1381
@NP	these 57 rats	1394
@NP	18	1409
@NP	5-HT immunostaining , 16 with BDA anterograde CST labeling	1430
@NP	5-HT immunostaining	1430
@NP	16 with BDA anterograde CST labeling	1451
@NP	16	1451
@NP	BDA anterograde CST labeling	1459
@NP	six	1493
@NP	transmission electron microscopy	1511
@NP	grafted animals	1548
@NP	behavioral recovery , sprouting	1565
@NP	behavioral recovery	1565
@NP	limited regeneration of 5-HT fibers	1600
@NP	limited regeneration	1600
@NP	5-HT fibers	1624
@NP	increased numbers	1641
@NP	proximal collateral processes but not regeneration	1662
@NP	proximal collateral processes	1662
@NP	regeneration	1700
@NP	CST fibers	1716
@NP	animals	1749
@NP	less	1761
@NP	cavitation in the spinal cord stumps than controls	1766
@NP	cavitation	1766
@NP	the spinal cord stumps than controls	1780
@NP	the spinal cord stumps	1780
@NP	controls	1808
@NP	Behavioral recovery	1818
@NP	three months	1848
@NP	Five POEG-transplanted animals that had shown behavioral recovery	1880
@NP	Five POEG-transplanted animals	1880
@NP	behavioral recovery	1926
@NP	retransection and behavioral scores	1956
@NP	retransection	1956
@NP	behavioral scores	1974
@NP	long tract axonal regeneration	2038
@NP	long tract	2038
@NP	axonal regeneration	2049
@NP	the locomotor improvement	2089
@NP	the ultrastructural level	2119
@NP	presumptive POEG	2145
@NP	direct contacts	2181
@NP	astrocytes	2202
@NP	the glia limitans , distinct from those formed by Schwann cells	2221
@NP	the glia limitans	2221
@NP	those formed by Schwann cells	2254
@NP	those	2254
@NP	Schwann cells	2270
@NP	6 weeks	2288
@NP	GFP expression	2296
@NP	cells within the lesion site	2327
@NP	cells	2327
@NP	the lesion site	2340
@NP	nerve roots	2367
@NP	the pattern of Hoechst nuclear labeling	2397
@NP	the pattern	2397
@NP	Hoechst nuclear labeling	2412
@NP	3.5 months	2441
@NP	only GFP-positive debris in macrophages	2452
@NP	only GFP-positive debris	2452
@NP	macrophages	2480
@NP	POEG support	2524
@NP	behavioral recovery	2537
@NP	mechanisms that appear to be independent	2561
@NP	mechanisms	2561
@NP	long tract regeneration	2605
@NP	Neuroprotective tissue sparing effects	3608
@NP	Takami et al. , 2002 ; Garcia-Alias et al. , 2004	3676
@NP	Takami	3676
@NP	et al. , 2002 ; Garcia-Alias et al. , 2004	3683
@NP	et al. , 2002	3683
@NP	et al.	3683
@NP	2002	3691
@NP	Garcia-Alias et al. , 2004	3697
@NP	Garcia-Alias	3697
@NP	et al. , 2004	3710
@NP	et al.	3710
@NP	2004	3718
@NP	The clinical efficacy and safety of OEGs	3724
@NP	The clinical efficacy and safety	3724
@NP	OEGs	3760
@NP	Dobkin	3793
@NP	et al. , 2006	3800
@NP	et al.	3800
@NP	2006	3808
@NP	Feron et al. , 2005	3814
@NP	Feron	3814
@NP	et al. , 2005	3820
@NP	et al.	3820
@NP	2005	3828
@NP	Guest et al. , 2006	3834
@NP	Guest	3834
@NP	et al. , 2006	3840
@NP	et al.	3840
@NP	2006	3848
@NP	Huang et al. , 2006	3854
@NP	Huang	3854
@NP	et al. , 2006	3860
@NP	et al.	3860
@NP	2006	3868
@NP	Lima et al. , 2006	3874
@NP	Lima	3874
@NP	et al. , 2006	3879
@NP	et al.	3879
@NP	2006	3887
@NP	lack of standardization of cell preparations	3908
@NP	lack	3908
@NP	standardization of cell preparations	3916
@NP	standardization	3916
@NP	cell preparations	3935
@NP	Most studies	3954
@NP	rodent cells	3981
@NP	the importance of testing the properties of primate and human OEG	3998
@NP	the importance	3998
@NP	the properties of primate and human OEG	4024
@NP	the properties	4024
@NP	primate and human OEG	4042
@NP	clinical implementation	4073
@NP	This	4123
@NP	autotransplantation	4152
@NP	only small tissue quantities	4189
@NP	host olfactory tissue	4242
@NP	expansion	4301
@NP	The properties of such expanded primate OEG	4312
@NP	The properties	4312
@NP	such expanded primate OEG	4330
@NP	such	4330
@NP	primate OEG	4344
@NP	it	4853
@NP	only OEG as opposed to SC	4884
@NP	only OEG	4884
@NP	SC	4907
@NP	nasal tissue	4951
@NP	the OEG source	4967
@NP	ongoing studies	4992
@NP	new methods	5039
@NP	OEGs	5065
@NP	SC	5075
@NP	Boyd et al. , 2006 ; Ibanez et al. , 2007 , Rizek and Kawaja , 2006	5079
@NP	Boyd et al.	5079
@NP	Boyd	5079
@NP	et al.	5084
@NP	2006 ; Ibanez et al.	5092
@NP	2006	5092
@NP	Ibanez et al.	5098
@NP	Ibanez	5098
@NP	et al.	5105
@NP	2007	5113
@NP	Rizek and Kawaja , 2006	5119
@NP	Rizek and Kawaja	5119
@NP	2006	5137
@NP	this study	5147
@NP	the olfactory bulb -LRB- OB -RRB-	5158
@NP	the olfactory bulb	5158
@NP	OB	5178
@NP	OEG	5205
@NP	inadvertent culture of SC	5220
@NP	inadvertent culture	5220
@NP	SC	5243
@NP	histological studies	5250
@NP	myelinated Schwann cell associated fibers	5291
@NP	myelinated Schwann cell	5291
@NP	fibers	5326
@NP	the OB -LRB- Herrera et al. , 2005 -RRB-	5352
@NP	the OB	5352
@NP	Herrera	5360
@NP	et al. , 2005	5368
@NP	et al.	5368
@NP	2005	5376
@NP	This experiment	5383
@NP	methods of immunopurification and cell expansion	5449
@NP	methods	5449
@NP	immunopurification and cell expansion	5460
@NP	rodent OEGs and human SC	5501
@NP	rodent OEGs	5501
@NP	human SC	5517
@NP	POEG , -LRB- Guest et al. , 1997a , b ; Ramon-Cueto et al. , 1998 -RRB-	5558
@NP	POEG	5558
@NP	Guest	5565
@NP	et al. , 1997a , b ; Ramon-Cueto et al. , 1998	5571
@NP	et al.	5571
@NP	1997a , b ; Ramon-Cueto et al.	5579
@NP	1997a , b	5579
@NP	1997a	5579
@NP	b	5585
@NP	Ramon-Cueto et al.	5588
@NP	Ramon-Cueto	5588
@NP	et al.	5600
@NP	1998	5608
@NP	the study	5638
@NP	Ramon-Cueto	5651
@NP	et al.	5663
@NP	Ramon-Cueto et al. , 2000 -RRB-	5671
@NP	Ramon-Cueto	5671
@NP	et al.	5683
@NP	2000	5691
@NP	testing	5698
@NP	expanded POEGs	5709
@NP	the same extent of recovery and repair	5738
@NP	the same extent	5738
@NP	recovery and repair	5757
@NP	long term duration of functional recovery ,	5786
@NP	long term duration of functional recovery	5786
@NP	long term duration	5786
@NP	functional recovery	5808
@NP	a subset of transplanted spinal cords	5852
@NP	a subset	5852
@NP	transplanted spinal cords	5864
@NP	such recovery	5912
@NP	the result of long tract regeneration	5929
@NP	the result	5929
@NP	long tract regeneration	5943
@NP	The ability	5968
@NP	transplanted POEG	5983
@NP	behavioral recovery and support axonal regeneration following transplantation	6012
@NP	behavioral recovery and support axonal regeneration	6012
@NP	transplantation	6074
@NP	comparison	6106
@NP	media-injected spinal transected nude rats	6128
@NP	A medium-only control	6172
@NP	a cellular control	6208
@NP	OEGs	6248
@NP	migration	6267
@NP	other cell types	6280
@NP	SC -LRB- Ramer et al. , 2004 ; Richter et al. , 2005 -RRB-	6305
@NP	SC	6305
@NP	Ramer	6309
@NP	et al. , 2004 ; Richter et al. , 2005	6315
@NP	et al.	6315
@NP	2004 ; Richter et al.	6323
@NP	2004	6323
@NP	Richter et al.	6329
@NP	Richter	6329
@NP	et al.	6337
@NP	2005	6345
@NP	the ultrastructural interpretation	6367
@NP	the baseline extent	6416
@NP	SC in-migration associated with the transection and injection procedure itself	6439
@NP	SC in-migration	6439
@NP	the transection and injection procedure itself	6471
@NP	the transection and injection procedure	6471
@NP	The majority of the animals in the study	6519
@NP	The majority	6519
@NP	the animals in the study	6535
@NP	the animals	6535
@NP	the study	6550
@NP	Hoechst-labeled cells	6583
@NP	availability of a lentiviral vector	6614
@NP	availability	6614
@NP	a lentiviral vector	6630
@NP	the validity of the Hoechst label	6668
@NP	the validity	6668
@NP	the Hoechst label	6684
@NP	an additional cohort of animalswas transplantedwith cells	6702
@NP	an additional cohort	6702
@NP	animalswas transplantedwith cells	6726
@NP	both Hoechst-labeled and lentivirallytransfected	6769
@NP	GFP	6829
@NP	Nude rats	6834
@NP	our previous experience inwhich	6867
@NP	we	6899
@NP	human Schwann cells	6932
@NP	spinal cord transection sites -LRB- Guest et al. , 1997a , b -RRB-	6957
@NP	spinal cord transection sites	6957
@NP	Guest	6988
@NP	et al. , 1997a , b	6994
@NP	et al.	6994
@NP	1997a	7002
@NP	b	7008
@NP	the chronic survival phase	7027
@NP	a decline in an initial behavioral recovery and progressive renal pathology	7054
@NP	a decline	7054
@NP	an initial behavioral recovery and progressive renal pathology	7067
@NP	an initial behavioral recovery	7067
@NP	progressive renal pathology	7102
@NP	these two variables	7144
@NP	severity of renal damage	7196
@NP	severity	7196
@NP	renal damage	7208
@NP	declining behavioral function	7241
@NP	The CST	7673
@NP	regeneration	7698
@NP	die-back	7712
@NP	terminal morphology	7722
@NP	the presence	7746
@NP	collateral processes	7762
@NP	Deumens	7784
@NP	et al. , 2006	7792
@NP	et al.	7792
@NP	2006	7800
@NP	Lopez-Vales et al. , 2006 , 2007	7806
@NP	Lopez-Vales	7806
@NP	et al. , 2006 , 2007	7818
@NP	et al.	7818
@NP	2006	7826
@NP	2007	7832
@NP	Lu et al. , 2006	7838
@NP	Lu	7838
@NP	et al. , 2006	7841
@NP	et al.	7841
@NP	2006	7849
@NP	Moreno-Flores et al. , 2006	7855
@NP	Moreno-Flores	7855
@NP	et al. , 2006	7869
@NP	et al.	7869
@NP	2006	7877
@NP	a correlation between 5-HT fiber regeneration and behavioral recovery	7887
@NP	a correlation	7887
@NP	5-HT fiber regeneration and behavioral recovery	7909
@NP	5-HT fiber regeneration	7909
@NP	behavioral recovery	7937
@NP	The area of spinal cord cavitation	7971
@NP	The area	7971
@NP	spinal cord cavitation	7983
@NP	the transplanted andmedia-only injected animals	8022
@NP	the relationships	8080
@NP	transplanted cells	8106
@NP	the spinal cord parenchyma containing reactive astrocytes and axons	8129
@NP	the spinal cord parenchyma	8129
@NP	reactive astrocytes and axons	8167
@NP	transmission electron microscopy -LRB- TEM -RRB-	8217
@NP	transmission electron microscopy	8217
@NP	TEM	8251
@NP	Materials and methods All nude rat experiments	8258
@NP	Materials	8258
@NP	methods All nude rat experiments	8272
@NP	methods	8272
@NP	All nude rat experiments	8280
@NP	approved IACUC protocols in accordance with NIH policy on the humane care	8326
@NP	approved IACUC protocols	8326
@NP	accordance	8354
@NP	NIH policy	8370
@NP	the humane care	8384
@NP	use of laboratory animals	8404
@NP	use	8404
@NP	laboratory animals	8411
@NP	Use of lentiviral vectors	8431
@NP	Use	8431
@NP	lentiviral vectors	8438
@NP	the University of Miami Institutional Biosafety Committee	8473
@NP	the University	8473
@NP	Miami Institutional Biosafety Committee	8491
@NP	Primate tissue harvest and cell culture Primate olfactory bulbs	8532
@NP	Primate tissue harvest and cell culture	8532
@NP	Primate olfactory bulbs	8572
@NP	following euthanasia in unrelated experiments	8610
@NP	following euthanasia	8610
@NP	unrelated experiments	8634
@NP	the University of Miami tissue sharing program	8664
@NP	the University of Miami tissue	8664
@NP	Miami	8682
@NP	program	8703
@NP	The healthy donor primates	8712
@NP	age from1 .5 to 10 years -LRB- mean 4.8 + / − 3 years SD -RRB-	8749
@NP	age from1 .5 to 10 years	8749
@NP	age from1	8749
@NP	.5 to 10 years	8758
@NP	4.8 + / − 3 years SD	8779
@NP	4.8 +	8779
@NP	− 3 years SD	8784
@NP	− 3 years	8784
@NP	SD	8793
@NP	Twelve primates	8798
@NP	Macaca mulata and five were Macaca fascicularis	8819
@NP	Macaca	8819
@NP	mulata and five	8826
@NP	mulata	8826
@NP	five	8837
@NP	Macaca fascicularis	8847
@NP	Therewere 11 males and 6 females with a mean weight of 4.9 + / − 2.2 kg SD .	8868
@NP	Therewere	8868
@NP	11 males and 6 females with a mean weight of 4.9 + / − 2.2 kg SD .	8878
@NP	11 males	8878
@NP	6 females with a mean weight of 4.9 + / − 2.2 kg SD .	8891
@NP	6 females	8891
@NP	a mean weight of 4.9 + / − 2.2 kg SD .	8906
@NP	a mean weight	8906
@NP	4.9 + / − 2.2 kg SD .	8923
@NP	4.9 +	8923
@NP	− 2.2	8928
@NP	kg SD	8933
@NP	The interval from death to tissue recovery	8940
@NP	The interval	8940
@NP	death to tissue recovery	8958
@NP	death	8958
@NP	tissue recovery	8967
@NP	3 h	8998
@NP	viable cells	9006
@NP	all specimens	9039
@NP	transport to the tissue culture facility	9058
@NP	transport	9058
@NP	the tissue culture facility	9071
@NP	the olfactory bulbs	9099
@NP	Liebovitz 's L15 media -LRB- GIBCO -RRB-	9134
@NP	Liebovitz 's L15 media	9134
@NP	Liebovitz 's	9134
@NP	GIBCO	9157
@NP	penicillin -LRB- 100 μg/μl -RRB-	9175
@NP	penicillin	9175
@NP	100 μg/μl	9187
@NP	streptomycin -LRB- 100 U/ml -RRB-	9199
@NP	streptomycin	9199
@NP	100 U/ml	9213
@NP	Fungizone	9228
@NP	2.5 μg/ml	9239
@NP	GIBCO	9250
@NP	Invitrogen	9257
@NP	ice	9281
@NP	dissection on the same day	9291
@NP	dissection	9291
@NP	the same day	9305
@NP	a dissecting microscope	9325
@NP	the ventral portion	9349
@NP	olfactory bulbs	9377
@NP	blood vessels and arachnoid	9424
@NP	blood vessels	9424
@NP	arachnoid	9442
@NP	The amberbrownish nerve fiber layerwas	9453
@NP	fromthewhitematter of the remaining olfactory bulb and tract	9507
@NP	fromthewhitematter	9507
@NP	the remaining olfactory bulb and tract	9529
@NP	the remaining olfactory bulb	9529
@NP	tract	9562
@NP	The dissected tissue	9569
@NP	0.05 % collagenase	9605
@NP	Worthington Biochemicals Corp.	9624
@NP	Freehold	9656
@NP	NJ	9666
@NP	0.25 %	9674
@NP	1.25 U/ml	9681
@NP	dispase -LRB- Boehringer Mannheim Biochemicals , Germany -RRB-	9692
@NP	dispase	9692
@NP	Boehringer Mannheim Biochemicals	9701
@NP	Germany	9735
@NP	DMEM -LRB- GIBCO , Invitrogen , Carlsbad , CA -RRB-	9747
@NP	DMEM	9747
@NP	GIBCO	9753
@NP	Invitrogen	9760
@NP	Carlsbad , CA	9772
@NP	10 % heat-inactivated fetal calf serum -LRB- HIFCS -RRB- overnight at 37 °C	9797
@NP	10 % heat-inactivated fetal calf serum -LRB- HIFCS -RRB- overnight	9797
@NP	10 % heat-inactivated fetal calf serum -LRB- HIFCS -RRB-	9797
@NP	10 %	9797
@NP	heat-inactivated fetal calf serum -LRB- HIFCS -RRB-	9801
@NP	heat-inactivated fetal calf serum	9801
@NP	HIFCS	9836
@NP	37 °C	9856
@NP	5 % CO2	9868
@NP	the tissue	9881
@NP	a flamenarrowed Pasteur pipette	9915
@NP	three times	9957
@NP	L-15	9972
@NP	the enzymes	9987
@NP	The cells	10000
@NP	a density of 500,000 cells	10030
@NP	a density	10030
@NP	500,000 cells	10043
@NP	100mmplastic tissue culture dishes	10062
@NP	Corning Life Sciences , Acton , MA	10098
@NP	Corning Life Sciences	10098
@NP	Acton , MA	10121
@NP	coatedwith	10132
@NP	rat-tail collagen	10154
@NP	The cellswere	10173
@NP	the mitogens heregulin -LRB- 10 nM , B1 subunit ; a gift from Genentech -RRB-	10198
@NP	the mitogens heregulin	10198
@NP	10 nM , B1 subunit ; a gift from Genentech	10222
@NP	10 nM	10222
@NP	B1 subunit ; a gift from Genentech	10229
@NP	B1 subunit	10229
@NP	a gift from Genentech	10241
@NP	a gift	10241
@NP	Genentech	10253
@NP	forskolin -LRB- 1 μM , Sigma -RRB- in DMEM	10269
@NP	forskolin -LRB- 1 μM , Sigma -RRB-	10269
@NP	forskolin	10269
@NP	1 μM	10280
@NP	Sigma	10286
@NP	DMEM	10296
@NP	10 % HIFCS	10312
@NP	The medium	10323
@NP	every three days	10346
@NP	The cell population	10364
@NP	seven days	10401
@NP	immunopanning	10421
@NP	seven days	10439
@NP	a single culture plate	10450
@NP	approximately 1.2 million cells	10483
@NP	p75 immunopanning	10516
@NP	p75 immunopanning	10538
@NP	Ramon-Cueto et al. , 1993	10557
@NP	Ramon-Cueto	10557
@NP	et al.	10569
@NP	1993	10577
@NP	goat antimouse Ab -LRB- Dako , Ely , UK -RRB-	10583
@NP	goat antimouse Ab	10583
@NP	Dako	10602
@NP	Ely	10608
@NP	UK	10613
@NP	a concentration of 10 μg/ml in 9 ml of 0.1 M Tris	10620
@NP	a concentration	10620
@NP	10 μg/ml in 9 ml of 0.1 M Tris	10639
@NP	10 μg/ml	10639
@NP	9 ml of 0.1 M Tris	10651
@NP	9 ml	10651
@NP	0.1 M Tris	10659
@NP	pH 9.5	10671
@NP	plastic Petri dishes -LRB- VWR Scientific Co. , West Chester , PA -RRB-	10694
@NP	plastic Petri dishes	10694
@NP	VWR Scientific Co.	10716
@NP	West Chester	10736
@NP	PA	10750
@NP	4 °C overnight	10757
@NP	4 °C	10757
@NP	The following day	10773
@NP	the immunopanning dish	10791
@NP	three times	10825
@NP	0.1 M Tris	10842
@NP	pH 9.5	10854
@NP	Mouse anti-primate p75	10863
@NP	8737 hybridoma supernatant	10887
@NP	American Type Culture Collection	10915
@NP	Manassas , VA	10949
@NP	a dilution of 1:5 in L15	10966
@NP	a dilution	10966
@NP	1:5 in L15	10980
@NP	1:5	10980
@NP	L15	10987
@NP	the dish	11006
@NP	room temperature for 1 h.	11018
@NP	room temperature	11018
@NP	1 h.	11039
@NP	OB cells	11053
@NP	the dish	11080
@NP	trypsinization	11092
@NP	three times	11128
@NP	DMEM	11143
@NP	the immunopanning plate	11170
@NP	an estimated total of 500,000 cells per 1 ml dish	11198
@NP	an estimated total	11198
@NP	500,000 cells per 1 ml dish	11220
@NP	500,000 cells	11220
@NP	1 ml dish	11238
@NP	Cells	11248
@NP	30 min at 4 °C and then non-adherent cellswerewashed off the dish	11281
@NP	30 min at 4 °C	11281
@NP	30 min	11281
@NP	4 °C	11291
@NP	then non-adherent cellswerewashed off the dish	11300
@NP	then non-adherent	11300
@NP	the dish	11338
@NP	The attached cells	11348
@NP	the presence of heregulin and forskolin	11384
@NP	the presence	11384
@NP	heregulin and forskolin	11400
@NP	the immunopanning platewas confluent	11430
@NP	the immunopanning platewas	11430
@NP	They	11468
@NP	confluence	11511
@NP	transplantation	11536
@NP	These third passage cells	11553
@NP	culture	11600
@NP	a total of approximately 27 -- 33 days	11612
@NP	a total of approximately 27	11612
@NP	a total	11612
@NP	approximately 27	11623
@NP	33 days	11640
@NP	The cells derived from the two olfactory bulbs of one primate	11649
@NP	The cells	11649
@NP	the two olfactory bulbs of one primate	11672
@NP	the two olfactory bulbs	11672
@NP	one primate	11699
@NP	3	11725
@NP	6 rodent transplantations	11727
@NP	the day of transplantation	11757
@NP	the day	11757
@NP	transplantation	11768
@NP	cells	11785
@NP	Hoechst -LRB- 33342 , Sigma , 1 μg/ml -RRB-	11809
@NP	Hoechst	11809
@NP	33342	11818
@NP	Sigma	11825
@NP	1 μg/ml	11832
@NP	Baron-Van Evercooren	11842
@NP	et al. , 1991	11863
@NP	et al.	11863
@NP	1991	11871
@NP	They	11878
@NP	the collagen-coated dishes	11916
@NP	them	11955
@NP	trypsin	11963
@NP	0.05 % -LRB- GIBCO / BRL -RRB- for 3 min	11971
@NP	0.05 % -LRB- GIBCO / BRL -RRB-	11971
@NP	0.05 %	11971
@NP	GIBCO	11978
@NP	BRL	11985
@NP	3 min	11994
@NP	collagenase -LRB- Type 1 , Worthington Biochemical , -RRB- 0.01 %	12009
@NP	collagenase -LRB- Type 1 , Worthington Biochemical , -RRB-	12009
@NP	collagenase	12009
@NP	Type 1	12022
@NP	Worthington Biochemical	12030
@NP	Worthington	12030
@NP	Biochemical	12042
@NP	0.01 %	12056
@NP	15 % fetal bovine serum -LRB- FBS -RRB-	12065
@NP	15 % fetal bovine serum	12065
@NP	FBS	12089
@NP	5 min	12098
@NP	They	12105
@NP	three times	12138
@NP	L-15	12155
@NP	a hemacytometer using trypan blue exclusion to assess the cell viability	12180
@NP	a hemacytometer	12180
@NP	trypan blue exclusion	12202
@NP	the cell viability	12234
@NP	Lentiviral transfection POEG prepared as above	12254
@NP	Lentiviral transfection POEG	12254
@NP	lentivirus 6/VS-GFP -LRB- courtesy of Dr.	12317
@NP	lentivirus	12317
@NP	6/VS-GFP -LRB- courtesy of Dr.	12328
@NP	6/VS-GFP	12328
@NP	courtesy of Dr.	12338
@NP	courtesy	12338
@NP	Dr.	12350
@NP	Bas Blits	12354
@NP	Bas	12354
@NP	Blits	12358
@NP	a vesicular stomatitis virus	12366
@NP	replication-incompetent vector driven by a cytomegalovirus promoter	12414
@NP	replication-incompetent vector	12414
@NP	a cytomegalovirus promoter	12455
@NP	the Woodchuck	12498
@NP	post-transcription regulatory element	12512
@NP	post-transcription	12512
@NP	regulatory element	12531
@NP	multiplicity of infection of 50:1 , 48 h prior	12554
@NP	multiplicity of infection of 50:1 , 48 h	12554
@NP	multiplicity	12554
@NP	infection	12570
@NP	50:1	12583
@NP	48 h	12589
@NP	transplantation	12603
@NP	24 h	12626
@NP	the cells	12631
@NP	three times	12653
@NP	DMEM	12670
@NP	regular culture media	12679
@NP	Fifty-seven adult female nude rats	12715
@NP	Taconic , Germantown , NY , NTac : NIH-Whn ,	12751
@NP	Taconic , Germantown , NY , NTac	12751
@NP	NIH-Whn	12782
@NP	140-155 g	12812
@NP	intramuscular rat cocktail	12846
@NP	ketamine	12874
@NP	43 mg/ml	12883
@NP	xylazine 8.6 mg	12893
@NP	xylazine	12893
@NP	8.6 mg	12902
@NP	ml ; acepromacine 1.4 mg/ml	12910
@NP	ml	12910
@NP	acepromacine 1.4 mg/ml	12914
@NP	0.5 ml/kg	12941
@NP	urinary infection	12963
@NP	Kefzol	12981
@NP	Cefaxolin sodium ; Eli Lily and Company , Indianapolis	12989
@NP	Cefaxolin sodium	12989
@NP	Eli Lily and Company , Indianapolis	13007
@NP	Eli Lily	13007
@NP	Company , Indianapolis	13020
@NP	15 mg/100 g body weight	13048
@NP	15 mg/100	13048
@NP	g body weight	13058
@NP	IM	13090
@NP	surgery	13102
@NP	recovery of spontaneous voiding	13148
@NP	recovery	13148
@NP	spontaneous voiding	13160
@NP	addition	13193
@NP	tetracycline -LRB- 1 mg/ml -RRB- and Vitamin C -LRB- 200 mg/L -RRB-	13202
@NP	tetracycline -LRB- 1 mg/ml -RRB-	13202
@NP	tetracycline	13202
@NP	1 mg/ml	13216
@NP	Vitamin C -LRB- 200 mg/L -RRB-	13229
@NP	Vitamin C	13229
@NP	200 mg/L	13240
@NP	drinking water	13264
@NP	chronic bacterial infection	13291
@NP	Baytril -LRB- 15 mg/kg IM bid -RRB-	13323
@NP	15 mg/kg IM bid	13332
@NP	urinary tract infection -LRB- UTI -RRB-	13369
@NP	urinary tract infection	13369
@NP	UTI	13394
@NP	the survival period	13416
@NP	The rats ' core temperature	13437
@NP	The rats '	13437
@NP	37	13482
@NP	− 0.5 °C	13486
@NP	surgery	13501
@NP	the immediate post-operative period ; all surgery	13520
@NP	the immediate post-operative period	13520
@NP	all surgery	13557
@NP	sterile conditions	13589
@NP	A thoracic laminectomy of T9 and T10	13609
@NP	A thoracic laminectomy	13609
@NP	T9 and T10	13635
@NP	the spinal cord	13664
@NP	the T9/T10 level	13694
@NP	Transections	13712
@NP	particular care	13758
@NP	the lateral spinal cord	13781
@NP	visualization of a gap of approximately 1 mm between the spinal cord stumps	13812
@NP	visualization	13812
@NP	a gap of approximately 1 mm between the spinal cord stumps	13829
@NP	a gap	13829
@NP	approximately 1 mm between the spinal cord stumps	13838
@NP	approximately 1 mm	13838
@NP	the spinal cord stumps	13865
@NP	a small sharp microhook	13902
@NP	the lateral dural margins	13937
@NP	not even thin strands of residual spinal cord	13978
@NP	not even thin strands	13978
@NP	residual spinal cord	14003
@NP	the transection	14047
@NP	Thirty-eight animals	14064
@NP	a POEG transplant and 19 control animals	14094
@NP	a POEG transplant	14094
@NP	19 control animals	14116
@NP	culture medium -LRB- L-15 -RRB- injections	14144
@NP	L-15	14160
@NP	control media or cellular injections	14182
@NP	control media	14182
@NP	cellular injections	14199
@NP	the pia mater	14219
@NP	a beveled 33 gauge needle	14253
@NP	the cell suspension or control mediawas	14286
@NP	the cell suspension	14286
@NP	control mediawas	14309
@NP	a 33 gauge	14343
@NP	stainless steel	14354
@NP	Hamilton needle	14382
@NP	Model 91033	14399
@NP	Hamilton Company	14412
@NP	Reno , Nevada	14430
@NP	a 5 μl syringe held in a Kopf stereotaxic micromanipulator	14456
@NP	a 5 μl syringe	14456
@NP	a Kopf stereotaxic micromanipulator	14479
@NP	The cells	14516
@NP	the rostral and caudal stumps	14545
@NP	the rostral	14545
@NP	caudal stumps	14561
@NP	the midline	14578
@NP	Ramon-Cueto	14606
@NP	et al.	14618
@NP	Ramon	14626
@NP	Cueto et al. , 2000 -RRB-	14633
@NP	Cueto	14633
@NP	et al. , 2000 -RRB-	14639
@NP	et	14639
@NP	al.	14642
@NP	2000	14647
@NP	Each animal	14654
@NP	a total of 400,000 cells	14675
@NP	a total	14675
@NP	400,000 cells	14686
@NP	50,000 cells in a 0.5 μl volume	14701
@NP	50,000 cells	14701
@NP	a 0.5 μl volume	14717
@NP	four depths -LRB- 200,000 cells/2 μl/stump -RRB-	14750
@NP	four depths	14750
@NP	200,000 cells/2 μl/stump	14763
@NP	200,000	14763
@NP	cells/2 μl/stump	14771
@NP	Injections	14790
@NP	pressure	14814
@NP	0.5 μl per minute	14826
@NP	0.5 μl	14826
@NP	minute	14837
@NP	the injection	14851
@NP	the needle	14878
@NP	the cord over 5 min	14913
@NP	the cord	14913
@NP	5 min	14927
@NP	cell extrusion	14943
@NP	the injection site	14963
@NP	The ventral dura mater	14983
@NP	the dorsal dura materwas	15022
@NP	10-0 absorbable sutures -LRB- Ethicon , Somerville , New Jersey -RRB-	15061
@NP	10-0 absorbable sutures	15061
@NP	Ethicon	15086
@NP	Somerville	15095
@NP	New Jersey	15107
@NP	the 38 POEG-transplanted animals	15123
@NP	five	15157
@NP	Basso	15169
@NP	Beattie , Bresnahan -LRB- BBB -RRB- -LRB- Basso et al. , 1995 -RRB- score	15176
@NP	Beattie , Bresnahan -LRB- BBB -RRB- -LRB- Basso et al. , 1995 -RRB-	15176
@NP	Beattie , Bresnahan -LRB- BBB -RRB-	15176
@NP	Beattie , Bresnahan	15176
@NP	BBB	15196
@NP	Basso	15202
@NP	et al. , 1995	15208
@NP	et al.	15208
@NP	1995	15216
@NP	score	15222
@NP	seven	15237
@NP	eight weeks	15246
@NP	retransection	15289
@NP	T9/10	15306
@NP	their BBB scores	15317
@NP	a subsequent four weeks	15352
@NP	Anterograde labeling of the corticospinal tract CST labeling	15377
@NP	Anterograde labeling	15377
@NP	the corticospinal tract CST labeling	15401
@NP	13 transplanted rats	15455
@NP	eight controls 17 -- 20 weeks following spinal cord transection	15480
@NP	eight controls 17	15480
@NP	eight controls	15480
@NP	17	15495
@NP	20 weeks following spinal cord transection	15498
@NP	20 weeks	15498
@NP	spinal cord transection	15517
@NP	Twenty-one days prior to euthanasia and perfusion the rats	15542
@NP	Twenty-one days	15542
@NP	euthanasia and perfusion	15567
@NP	anesthesia	15611
@NP	rat cocktail -LRB- 0.5 ml/kg -RRB-	15627
@NP	rat cocktail	15627
@NP	0.5 ml/kg	15641
@NP	Bilateral craniotomies	15653
@NP	a surgical drill and 10 % biotinylated dextran amine -LRB- BDA ,10,000	15694
@NP	a surgical drill	15694
@NP	10 % biotinylated dextran amine -LRB- BDA ,10,000	15715
@NP	10 %	15715
@NP	dextran amine -LRB- BDA ,10,000	15732
@NP	dextran	15732
@NP	amine -LRB- BDA ,10,000	15740
@NP	amine	15740
@NP	BDA ,10,000	15747
@NP	BDA	15747
@NP	,10,000	15750
@NP	M.W.	15759
@NP	D1956 , Molecular Probes Inc , Eugene , OR -RRB-	15764
@NP	D1956	15764
@NP	Molecular Probes Inc , Eugene , OR -RRB-	15771
@NP	Molecular Probes Inc	15771
@NP	Eugene	15793
@NP	OR	15801
@NP	the motor cortex bilaterally -LRB- Guest et al. , 1997a , b -RRB-	15823
@NP	the motor cortex bilaterally	15823
@NP	the motor cortex	15823
@NP	Guest	15853
@NP	et al. , 1997a , b	15859
@NP	et al.	15859
@NP	1997a	15867
@NP	b	15873
@NP	Five injections of 0.2 μl	15877
@NP	Five injections	15877
@NP	0.2 μl	15896
@NP	side	15922
@NP	a depth of 0.7 mmfrom the cortical surface	15930
@NP	a depth	15930
@NP	0.7 mmfrom the cortical surface	15941
@NP	0.7 mmfrom	15941
@NP	the cortical surface	15952
@NP	The injections	15974
@NP	between 1 and 3 mm posterior	16001
@NP	the bregma and 2 to 3 mm	16033
@NP	the bregma	16033
@NP	2 to 3 mm	16048
@NP	the midline -LRB- sagittal suture -RRB-	16063
@NP	the midline	16063
@NP	sagittal suture	16076
@NP	Behavioral testing	16094
@NP	open field	16114
@NP	Nude rats	16125
@NP	the open field	16155
@NP	Basso et al.	16186
@NP	Basso	16186
@NP	et al.	16192
@NP	-LRB- Basso et al. , 1995 -RRB- twice prior to surgery .	16199
@NP	Basso	16200
@NP	et al. , 1995 -RRB- twice prior	16206
@NP	et al. , 1995 -RRB-	16206
@NP	et	16206
@NP	al.	16209
@NP	1995	16214
@NP	surgery	16235
@NP	spinal cord transection	16254
@NP	the ratswere	16278
@NP	the entire duration	16316
@NP	their survival.Two observers	16339
@NP	a BBB score and then the mean score	16391
@NP	a BBB score	16391
@NP	the mean score	16412
@NP	addition	16444
@NP	the open field sessions	16453
@NP	further analysis	16498
@NP	the animal coding employed	16523
@NP	the animal	16523
@NP	the testers	16551
@NP	they	16579
@NP	an OEGtransplanted , or control media-injected rat	16600
@NP	an OEGtransplanted	16600
@NP	an	16600
@NP	control media-injected rat	16623
@NP	The scores of transplanted animals versus controls	16651
@NP	The scores	16651
@NP	transplanted animals versus controls	16665
@NP	transplanted animals	16665
@NP	controls	16693
@NP	two-way ANOVA followed by a Bonferroni	16722
@NP	two-way ANOVA	16722
@NP	a Bonferroni	16748
@NP	multiple comparisons	16786
@NP	The scores of the animals	16808
@NP	The scores	16808
@NP	the animals	16822
@NP	retransectionwere assessed using a paired t-test	16847
@NP	retransectionwere	16847
@NP	a paired t-test	16880
@NP	Ascent	16897
@NP	a wire mesh ramp A wire mesh grid walk	16907
@NP	25 mm × 25 mm	16947
@NP	25 mm ×	16947
@NP	25 mm	16953
@NP	whose angle	16960
@NP	ascent	16975
@NP	Ramon-Cueto et al.	17014
@NP	Ramon-Cueto	17014
@NP	et al.	17026
@NP	-LRB- Ramon-Cueto et al. , 2000 -RRB-	17033
@NP	Ramon-Cueto	17034
@NP	et al. , 2000	17046
@NP	et al.	17046
@NP	2000	17054
@NP	Control-injected and transplanted rats	17077
@NP	Control-injected	17077
@NP	transplanted rats	17098
@NP	their ability to ascend this ramp once weekly throughout the study	17134
@NP	this ramp	17158
@NP	weekly throughout the study	17173
@NP	weekly	17173
@NP	the study	17191
@NP	The ramp	17202
@NP	45 degrees	17232
@NP	the steepest angle	17247
@NP	60 , 75 and 90 degrees	17267
@NP	60	17267
@NP	75	17271
@NP	90 degrees	17278
@NP	the rats	17299
@NP	at least 30 cm within 1 min	17321
@NP	at least 30 cm	17321
@NP	1 min	17343
@NP	a tester blinded to the rat 's control or transplant status	17367
@NP	a tester	17367
@NP	the rat 's control or transplant status	17387
@NP	the rat 's	17387
@NP	The maximum ascent angles per session	17427
@NP	The maximum ascent angles	17427
@NP	session	17457
@NP	POEG-transplanted , or controlmedia	17487
@NP	POEG-transplanted	17487
@NP	controlmedia	17509
@NP	rats	17532
@NP	Assessment of renal system injury and correlation with BBB scores	17557
@NP	Assessment	17557
@NP	renal system injury and correlation with BBB scores	17571
@NP	renal system injury and correlation	17571
@NP	BBB scores	17612
@NP	the weight loss and decline in BBB scores of several of the nude rats	17630
@NP	the weight loss and decline	17630
@NP	BBB scores of several of the nude rats	17661
@NP	BBB scores	17661
@NP	several of the nude rats	17675
@NP	several	17675
@NP	the nude rats	17686
@NP	complete post-mortem autopsies	17701
@NP	one of the authors -LRB- M.O. -RRB- , a qualified veterinarian	17750
@NP	one of the authors -LRB- M.O. -RRB-	17750
@NP	one	17750
@NP	the authors -LRB- M.O. -RRB-	17757
@NP	the authors	17757
@NP	M.O.	17770
@NP	a qualified veterinarian	17777
@NP	All organ systems	17803
@NP	evidence of gross injury	17839
@NP	evidence	17839
@NP	gross injury	17851
@NP	The renal system	17865
@NP	the anterior bladder wall	17898
@NP	the kidneys	17935
@NP	the plane of their renal calyx	17959
@NP	the plane	17959
@NP	their renal calyx	17972
@NP	Ten animals	17991
@NP	urine cultures and renal stoneswere analyzed fromsix animals	18007
@NP	urine cultures	18007
@NP	renal stoneswere analyzed fromsix animals	18026
@NP	renal stoneswere	18026
@NP	fromsix animals	18052
@NP	A scorewas	18069
@NP	grade	18093
@NP	the severity of renal damage	18099
@NP	the severity	18099
@NP	renal damage	18115
@NP	the gross level	18139
@NP	this	18159
@NP	the value	18184
@NP	the BBB score decline -LRB- peak BBB score − terminal BBB score -RRB-	18197
@NP	the BBB score decline	18197
@NP	peak BBB score − terminal BBB score	18220
@NP	peak	18220
@NP	BBB score − terminal BBB score	18225
@NP	BBB score	18225
@NP	− terminal BBB score	18234
@NP	Spearman 's correlation test	18262
@NP	Spearman 's	18262
@NP	GraphPad Instat , version 3.05	18293
@NP	GraphPad Instat	18293
@NP	version 3.05	18310
@NP	The severity of renal damage	18324
@NP	The severity	18324
@NP	renal damage	18340
@NP	0 -- 5	18369
@NP	the presence of calculi in the bladder -LRB- 1 point -RRB-	18390
@NP	the presence	18390
@NP	calculi in the bladder -LRB- 1 point -RRB-	18406
@NP	calculi	18406
@NP	the bladder -LRB- 1 point -RRB-	18417
@NP	the bladder	18417
@NP	1 point	18430
@NP	the kidneys -LRB- 2 points -RRB-	18459
@NP	the kidneys	18459
@NP	2 points	18472
@NP	Renal tissue loss or evidence of infarctionwas	18483
@NP	Renal tissue loss or evidence	18483
@NP	infarctionwas	18516
@NP	from0 -- 3 points	18537
@NP	from0	18537
@NP	3 points	18543
@NP	this scale animals	18559
@NP	no calculi and normal appearing kidneys	18583
@NP	no calculi	18583
@NP	normal appearing kidneys	18598
@NP	0 points and those with severe calculi and renal tissue loss score 5 points	18629
@NP	0 points and those with severe calculi	18629
@NP	0 points	18629
@NP	those with severe calculi	18642
@NP	those	18642
@NP	severe calculi	18653
@NP	renal tissue loss score 5 points	18672
@NP	renal tissue loss score	18672
@NP	5 points	18696
@NP	Histological examination of the spinal cord	18706
@NP	Histological examination	18706
@NP	the spinal cord	18734
@NP	survival time points	18753
@NP	23 to 24 weeks	18787
@NP	six and 16 weeks for GFP-labeled cells	18803
@NP	six and 16 weeks	18803
@NP	GFP-labeled cells	18824
@NP	the rodents	18843
@NP	injection	18865
@NP	a lethal dose of rat cocktail and then trans-cardiac perfusion with saline	18878
@NP	a lethal dose of rat cocktail	18878
@NP	a lethal dose	18878
@NP	rat cocktail	18895
@NP	trans-cardiac perfusion with saline	18917
@NP	trans-cardiac perfusion	18917
@NP	saline	18946
@NP	heparin -LRB- 5000 U.I / L -RRB- followed by 4 %	18964
@NP	heparin -LRB- 5000 U.I / L -RRB-	18964
@NP	heparin	18964
@NP	5000 U.I	18973
@NP	L	18982
@NP	4 %	18997
@NP	paraformaldehyde	19009
@NP	perfusion	19037
@NP	the transection	19047
@NP	thorough inspection of the spinal cord	19088
@NP	thorough inspection	19088
@NP	the spinal cord	19111
@NP	a dissecting microscope	19133
@NP	each studied spinal cord	19162
@NP	each	19162
@NP	spinal cord	19175
@NP	a segment	19188
@NP	the transection site	19212
@NP	10 mm of the rostral and distal spinal cord	19247
@NP	10 mm	19247
@NP	the rostral and distal spinal cord	19256
@NP	the rostral	19256
@NP	distal spinal cord	19272
@NP	gelatin -LRB- Oudega et al. ,1994 -RRB-	19319
@NP	gelatin	19319
@NP	Oudega et al. ,1994	19328
@NP	Oudega	19328
@NP	et al. ,1994	19335
@NP	et al.	19335
@NP	,1994	19341
@NP	KPBS -LRB- 0.1 M -RRB-	19369
@NP	KPBS	19369
@NP	0.1 M	19375
@NP	20 % sucrose	19393
@NP	overnight at 4 °C	19405
@NP	overnight	19405
@NP	4 °C	19418
@NP	labeled CST fibers	19434
@NP	the transection	19481
@NP	the spinal cords	19510
@NP	the sagittal or coronal plane	19545
@NP	the sagittal	19545
@NP	coronal plane	19561
@NP	40 μm using a sliding freezingmicrotome	19578
@NP	40 μm	19578
@NP	a sliding freezingmicrotome	19590
@NP	The	19619
@NP	the tract terminals	19631
@NP	the dorsal	19667
@NP	ventral or horizontal plane	19678
@NP	both 5-HT immunostaining and comparison of GFP to Hoechst cellular labeling	19711
@NP	both 5-HT immunostaining and comparison	19711
@NP	GFP to Hoechst cellular labeling	19754
@NP	GFP	19754
@NP	Hoechst cellular labeling	19761
@NP	10 μm sagittal or coronal sections	19787
@NP	10 μm sagittal	19787
@NP	coronal sections	19805
@NP	the left to the right of the spinal cord on a rotatory cryostat	19836
@NP	the right of the spinal cord on a rotatory	19848
@NP	the right	19848
@NP	the spinal cord on a rotatory	19861
@NP	the spinal cord	19861
@NP	a rotatory	19880
@NP	gelatin-coated slides	19929
@NP	Specimens	19952
@NP	their respective identity as control or transplant	19981
@NP	their respective identity	19981
@NP	control or transplant	20010
@NP	the assessor	20049
@NP	Comparison	20063
@NP	the distribution of Hoechst and GFP-positive cells Sagittal tissue sections	20077
@NP	the distribution of Hoechst	20077
@NP	the distribution	20077
@NP	Hoechst	20097
@NP	GFP-positive cells Sagittal tissue sections	20109
@NP	GFP-positive cells	20109
@NP	Sagittal tissue sections	20128
@NP	appropriate fluorescent wavelengths	20174
@NP	a Zeiss Axiophot microscope	20216
@NP	a color camera equipped with Neurolucida software	20249
@NP	a color camera	20249
@NP	Neurolucida software	20278
@NP	Image montages	20300
@NP	magnifications of 200 × and 400 × and the relative distribution of GFP	20332
@NP	magnifications	20332
@NP	200 × and 400 × and the relative distribution of GFP	20350
@NP	200 × and 400 ×	20350
@NP	200 ×	20350
@NP	400 ×	20359
@NP	the relative distribution of GFP	20368
@NP	the relative distribution	20368
@NP	GFP	20397
@NP	Hoechst-positive cells compared	20405
@NP	Hoechst-positive cells	20405
@NP	Anti 5-HT	20438
@NP	goat-anti-rabbit polyclonal , Incstar Corp , Stillwater , MN	20449
@NP	goat-anti-rabbit polyclonal	20449
@NP	Incstar Corp	20478
@NP	Stillwater	20492
@NP	MN	20504
@NP	immunostaining	20508
@NP	serial 10 μm sagittal or coronal sections	20540
@NP	serial 10 μm sagittal	20540
@NP	coronal sections	20565
@NP	twelve OEG-transplanted and six control rats	20587
@NP	six control	20615
@NP	The sections	20633
@NP	pre-incubation	20662
@NP	2 % bovine serum albumin -LRB- Sigma Chemical Co.	20680
@NP	bovine serum albumin -LRB- Sigma Chemical Co.	20683
@NP	bovine serum albumin	20683
@NP	Sigma Chemical Co.	20705
@NP	Sigma	20705
@NP	Chemical Co.	20711
@NP	St.	20724
@NP	Louis , MO -RRB- and 10 %	20728
@NP	Louis , MO -RRB-	20728
@NP	Louis	20728
@NP	10 %	20743
@NP	serum in KPBS -LRB- 0.1 M -RRB-	20752
@NP	serum	20752
@NP	KPBS -LRB- 0.1 M -RRB-	20761
@NP	KPBS	20761
@NP	0.1 M	20767
@NP	non-specific binding	20785
@NP	The sections	20807
@NP	the anti 5-HT antibodies at a concentration of 1:2000	20841
@NP	the anti 5-HT antibodies	20841
@NP	a concentration of 1:2000	20869
@NP	a concentration	20869
@NP	1:2000	20888
@NP	KPBS containing 2 % goat serum and 0.1 % Triton-X overnight at 4 °C	20898
@NP	KPBS	20898
@NP	2 % goat serum and 0.1 % Triton-X overnight at 4 °C	20914
@NP	2 % goat serum	20914
@NP	0.1 % Triton-X	20932
@NP	overnight at 4 °C	20946
@NP	overnight	20946
@NP	4 °C	20959
@NP	then	20969
@NP	three times	20981
@NP	KPBS	20998
@NP	Secondary antibody -LRB- Alexa Fluor 488 , Molecular Probes -RRB-	21004
@NP	Secondary antibody	21004
@NP	Alexa Fluor 488 , Molecular Probes	21024
@NP	Alexa Fluor 488	21024
@NP	Molecular Probes	21041
@NP	1 h at room temperature at a 1:100 dilution	21075
@NP	1 h	21075
@NP	room temperature at a 1:100 dilution	21082
@NP	room temperature	21082
@NP	a 1:100 dilution	21102
@NP	KPBS followed by three washes	21122
@NP	KPBS	21122
@NP	three washes	21139
@NP	immunostaining	21163
@NP	the sections	21178
@NP	Citifluor -LRB- UKC Chemical laboratory -RRB-	21208
@NP	Citifluor	21208
@NP	UKC Chemical laboratory	21219
@NP	UKC Chemical	21219
@NP	laboratory	21232
@NP	Digital images	21263
@NP	a Zeiss Axiophot microscope	21298
@NP	a digital video camera connected to a workstation running Neurolucida software	21331
@NP	a digital video camera	21331
@NP	a workstation running Neurolucida software	21367
@NP	a workstation	21367
@NP	Neurolucida software	21389
@NP	the relationship between immunopositive fibers and the transection site	21433
@NP	the relationship	21433
@NP	immunopositive fibers and the transection site	21458
@NP	immunopositive fibers	21458
@NP	the transection site	21484
@NP	image montages	21506
@NP	each	21524
@NP	the 10 contiguous sections	21532
@NP	the greatest density of 5-HT fiber labeling in each spinal cord	21564
@NP	the greatest density	21564
@NP	5-HT fiber labeling in each spinal cord	21588
@NP	5-HT fiber labeling	21588
@NP	each spinal cord	21611
@NP	Neurolucida	21648
@NP	Adobe Photoshop	21681
@NP	The number of 5	21698
@NP	The number	21698
@NP	5	21712
@NP	HT positive fibers was linearly correlated with peak BBB scores	21715
@NP	HT	21715
@NP	positive fibers	21718
@NP	peak BBB scores	21763
@NP	Assessment for regeneration , die-back , sprouting	21780
@NP	Assessment for regeneration	21780
@NP	Assessment	21780
@NP	regeneration	21795
@NP	die-back	21809
@NP	terminalmorphology of the labeled CST	21833
@NP	terminalmorphology	21833
@NP	the labeled CST	21855
@NP	confirmation	21876
@NP	SCI completeness To identify anterogradely transported BDA in CST processes	21892
@NP	SCI completeness To identify anterogradely	21892
@NP	BDA in CST processes	21947
@NP	BDA	21947
@NP	CST processes	21954
@NP	the spinal cord segments of thirteen transplanted and eight control animals	21969
@NP	the spinal cord segments	21969
@NP	thirteen transplanted and eight control animals	21997
@NP	thirteen transplanted	21997
@NP	eight control animals	22023
@NP	gelatin and cut	22062
@NP	40 μm sagittal or coronal sections from the entire spinal cord	22098
@NP	40 μm sagittal or coronal sections	22098
@NP	the entire spinal cord	22138
@NP	24	22190
@NP	plates	22198
@NP	The sections	22206
@NP	0.5 % hydrogen peroxide -LRB- H2O2 -RRB-	22235
@NP	0.5 % hydrogen peroxide	22235
@NP	H2O2	22259
@NP	30 min	22269
@NP	endogenous peroxide	22286
@NP	they	22312
@NP	biotin peroxidase -LRB- PK-6105 Elite , Vector , Burlingame	22340
@NP	biotin peroxidase	22340
@NP	PK-6105 Elite	22359
@NP	Vector , Burlingame	22374
@NP	Ca . -RRB-	22394
@NP	Ca	22394
@NP	1/800 dilution for 2 h at room temperature	22402
@NP	1/800 dilution	22402
@NP	2 h at room temperature	22421
@NP	2 h	22421
@NP	room temperature	22428
@NP	The sections	22446
@NP	four times	22471
@NP	0.25 M Tris	22487
@NP	saline	22508
@NP	DAB -LRB- 0.04 % -RRB- and NiCl2 -LRB- 0.06 % -RRB-	22535
@NP	DAB	22535
@NP	0.04 %	22540
@NP	NiCl2	22551
@NP	0.06 %	22558
@NP	20 min	22569
@NP	the presence of H2O2 -LRB- 0.015 % -RRB- -LRB- Guest et al. , 1997a , b -RRB-	22579
@NP	the presence	22579
@NP	H2O2 -LRB- 0.015 % -RRB- -LRB- Guest et al. , 1997a , b -RRB-	22595
@NP	H2O2 -LRB- 0.015 % -RRB-	22595
@NP	H2O2	22595
@NP	0.015 %	22601
@NP	Guest	22610
@NP	et al. , 1997a , b	22616
@NP	et al.	22616
@NP	1997a	22624
@NP	b	22630
@NP	The position	22634
@NP	the labeled CST fibers	22650
@NP	terminals , the transection site and any cavities and macrophage clusters	22677
@NP	terminals	22677
@NP	the transection site	22688
@NP	any cavities and macrophage clusters	22713
@NP	sequential sections	22767
@NP	a Zeiss Axiophot microscope connected to a computer running Neurolucida	22793
@NP	a Zeiss Axiophot microscope	22793
@NP	a computer running Neurolucida	22834
@NP	a computer	22834
@NP	Neurolucida	22853
@NP	The sequential sections	22866
@NP	an autofluorescent image montage	22909
@NP	interpretation of the terminals and fiber sprouts	22956
@NP	interpretation	22956
@NP	the terminals and fiber sprouts	22974
@NP	relation	23009
@NP	the transection site	23021
@NP	Two additional analyses of these images	23043
@NP	Two additional analyses	23043
@NP	these images	23070
@NP	CST fibers	23108
@NP	evidence and quantification of primary collateral formation	23137
@NP	evidence and quantification	23137
@NP	primary collateral formation	23168
@NP	5 mm of the lesion site	23204
@NP	5 mm	23204
@NP	the lesion site	23212
@NP	A primary collateral process	23229
@NP	a process that emerged at right angles to a longitudinally-oriented CST process	23273
@NP	a process	23273
@NP	right angles	23299
@NP	a longitudinally-oriented CST process	23315
@NP	this analysis	23365
@NP	the 10 contiguous sections	23380
@NP	the CSTwas	23416
@NP	BDA in each animal	23453
@NP	BDA	23453
@NP	each animal	23460
@NP	The number of longitudinally-oriented processes	23487
@NP	The number	23487
@NP	longitudinally-oriented processes	23501
@NP	at least 150 μm	23535
@NP	length in each section and the total number of perpendicular processes	23554
@NP	length in each section	23554
@NP	length	23554
@NP	each section	23564
@NP	the total number of perpendicular processes	23581
@NP	the total number	23581
@NP	perpendicular processes	23601
@NP	a definite continuity	23634
@NP	the longitudinal process	23678
@NP	the primary collateral branch emerging from it	23707
@NP	the primary collateral branch	23707
@NP	it	23751
@NP	Hirata and Fujisawa	23768
@NP	1999	23789
@NP	The total number of such processes	23796
@NP	The total number	23796
@NP	such processes	23816
@NP	two regions : 0 -- 2.5 mm , and 2.5 to 5.0 mm rostral	23857
@NP	two regions	23857
@NP	0	23870
@NP	2.5 mm	23872
@NP	2.5 to 5.0 mm rostral	23884
@NP	the transection site	23909
@NP	the number	23940
@NP	definite primary collateral processes per longitudinal process per mm	23954
@NP	definite primary collateral processes	23954
@NP	longitudinal process per mm	23996
@NP	longitudinal process	23996
@NP	mm	24021
@NP	this	24028
@NP	a ratio	24050
@NP	it	24059
@NP	the fact	24097
@NP	the total number of labeled CST fibers	24111
@NP	the total number	24111
@NP	labeled CST fibers	24131
@NP	animals	24166
@NP	CST terminals	24185
@NP	round , fusiform , and filopodial	24218
@NP	round	24218
@NP	fusiform	24225
@NP	filopodial	24239
@NP	Hill et al. , 2004	24267
@NP	Hill	24267
@NP	et al.	24272
@NP	2004	24280
@NP	addition	24290
@NP	en-passant varicosities	24299
@NP	at least 20 μm of axon	24342
@NP	at least 20 μm	24342
@NP	axon	24360
@NP	either side of the distension	24368
@NP	either side	24368
@NP	the distension	24383
@NP	numbers of a	24426
@NP	numbers	24426
@NP	a	24437
@NP	round , b -RRB- fusiform + filopodial CST terminals and c	24440
@NP	round , b -RRB- fusiform	24440
@NP	filopodial CST terminals and c	24459
@NP	longitudinal fibers or collateral branches	24531
@NP	the five terminal mm of BDA anterograde	24590
@NP	the five terminal mm	24590
@NP	five	24594
@NP	BDA anterograde	24614
@NP	CST of control and OEG-transplanted rats	24637
@NP	CST	24637
@NP	control and OEG-transplanted rats	24644
@NP	Assessment	24679
@NP	transplanted POEG	24734
@NP	loss of parenchyma fromthe spinal cord stumpswe	24760
@NP	loss	24760
@NP	parenchyma fromthe spinal cord stumpswe	24768
@NP	parenchyma fromthe	24768
@NP	the volume of cavitieswithin	24818
@NP	the volume	24818
@NP	cavitieswithin	24832
@NP	the parenchyma in a subset of control injected -LRB- n = 5 -RRB-	24847
@NP	the parenchyma in a subset of control injected	24847
@NP	the parenchyma	24847
@NP	a subset of control injected	24865
@NP	a subset	24865
@NP	control injected	24877
@NP	control	24877
@NP	n	24895
@NP	5	24897
@NP	POEG -LRB- n = 5 -RRB- transplanted rats	24904
@NP	POEG -LRB- n = 5 -RRB-	24904
@NP	POEG	24904
@NP	n	24910
@NP	5	24912
@NP	rats	24928
@NP	Sagittal sections	24934
@NP	at least 5 mm above	24962
@NP	at least 5 mm	24962
@NP	belowthe transection sitewere examined under autofluorescence	24986
@NP	belowthe transection sitewere	24986
@NP	autofluorescence	25031
@NP	10 × and photomontages	25051
@NP	10 ×	25051
@NP	photomontages	25059
@NP	Neurolucida	25084
@NP	.	25096
@NP	The region of maximum cavitation	25098
@NP	The region	25098
@NP	maximum cavitation	25112
@NP	every 10 section -LRB- 10 μm thick sections -RRB-	25155
@NP	every 10 section	25155
@NP	10 μm thick sections	25173
@NP	10 μm	25173
@NP	thick sections	25179
@NP	a distance of 600 μmlaterally -LRB- total 1.2 mm -RRB-	25211
@NP	a distance of 600 μmlaterally	25211
@NP	a distance	25211
@NP	600	25225
@NP	total 1.2 mm	25242
@NP	total	25242
@NP	1.2 mm	25248
@NP	Cavities	25256
@NP	Neurolucida and the area determined	25287
@NP	Neurolucida	25287
@NP	the area determined	25303
@NP	the area	25303
@NP	The 12 area measurements thus obtained	25324
@NP	The 12 area measurements	25324
@NP	the distance between the sections -LRB- 100 μm -RRB-	25392
@NP	the distance	25392
@NP	the sections -LRB- 100 μm -RRB-	25413
@NP	the sections	25413
@NP	100 μm	25427
@NP	average volumes of cavitation	25447
@NP	average volumes	25447
@NP	cavitation	25466
@NP	These	25478
@NP	a 2	25504
@NP	t-test	25515
@NP	Instat 3.05	25525
@NP	Ultrastructural examination Six animals	25538
@NP	Ultrastructural examination	25538
@NP	Six animals	25566
@NP	3 controls and 3 POEG , transplanted for 8weeks	25579
@NP	3 controls and 3 POEG ,	25579
@NP	3 controls	25579
@NP	3 POEG	25594
@NP	8weeks	25619
@NP	transmission electron microscopy -LRB- TEM -RRB-	25640
@NP	transmission electron microscopy	25640
@NP	TEM	25674
@NP	A region	25680
@NP	the spinal cord stump and associated scar across the transection gap	25699
@NP	the spinal cord stump	25699
@NP	associated scar across the transection gap	25725
@NP	associated scar	25725
@NP	the transection gap	25748
@NP	2 % glutaraldehyde	25788
@NP	1 % osmium	25818
@NP	Araldite	25841
@NP	toluidine blue	25868
@NP	each	25888
@NP	animal regions of interest	25899
@NP	animal regions	25899
@NP	interest	25917
@NP	the scar tissue between the stumps	25938
@NP	the scar tissue	25938
@NP	the stumps	25962
@NP	the spinal cord scar interface	25977
@NP	the spinal cord	26020
@NP	stumps	26036
@NP	1 μm plastic sections	26062
@NP	ultra-thin sections	26089
@NP	a Philips CM10 electron microscope	26142
@NP	The EM grids	26178
@NP	axons at 1650 ×	26209
@NP	axons	26209
@NP	1650 ×	26218
@NP	20 representative photomicrographs	26228
@NP	The	26278
@NP	notable structureswere	26298
@NP	reviewof the initial images further	26340
@NP	reviewof	26340
@NP	the initial images	26349
@NP	images	26376
@NP	6000	26400
@NP	14000 ×	26408
@NP	Results Fig. 1 .	26417
@NP	Results	26417
@NP	Fig. 1	26425
@NP	Culture and immunopanning of primate olfactory ensheathing glia .	26433
@NP	Culture and immunopanning	26433
@NP	primate olfactory ensheathing glia	26462
@NP	A.	26498
@NP	S-100 -LRB- Dako polyclonal , 1/100 , red -RRB- and p75	26501
@NP	S-100 -LRB- Dako polyclonal , 1/100 , red -RRB-	26501
@NP	S-100	26501
@NP	Dako polyclonal , 1/100 , red	26508
@NP	Dako polyclonal	26508
@NP	1/100	26525
@NP	red	26532
@NP	p75	26541
@NP	8737 hybridoma supernatant	26546
@NP	American Type Culture Collection	26574
@NP	Manassas	26608
@NP	VA	26618
@NP	green	26622
@NP	immunostaining of a primate OEG culture following p-75 immunopanning	26629
@NP	immunostaining	26629
@NP	a primate OEG culture following p-75 immunopanning	26647
@NP	a primate OEG culture	26647
@NP	p-75 immunopanning	26679
@NP	A large S-100	26699
@NP	p75 negative cell -LRB- white arrow -RRB-	26723
@NP	p75 negative cell	26723
@NP	white arrow	26742
@NP	an astrocyte	26762
@NP	B.	26776
@NP	Flat tripolar -LRB- left , arrowhead -RRB- and spindly bipolar -LRB- right -RRB-	26779
@NP	Flat tripolar -LRB- left , arrowhead -RRB- and spindly bipolar	26779
@NP	left , arrowhead	26794
@NP	left	26794
@NP	arrowhead	26800
@NP	the primary cultures	26857
@NP	C.	26879
@NP	A primate olfactory bulb	26882
@NP	axial section	26919
@NP	culture	26938
@NP	the blood vessels , meninges , and fila olfactoria -LRB- arrow -RRB-	26946
@NP	the blood vessels , meninges , and fila olfactoria	26946
@NP	the blood vessels	26946
@NP	meninges	26965
@NP	fila olfactoria	26979
@NP	arrow	26996
@NP	the nerve fiber layer	27021
@NP	the remaining OB	27072
@NP	D.	27118
@NP	The impact of antip75 immunopanning	27121
@NP	The impact	27121
@NP	antip75 immunopanning	27135
@NP	one week on the total cell numbers in the culture	27170
@NP	one week	27170
@NP	the total cell numbers in the culture	27182
@NP	the total cell numbers	27182
@NP	the culture	27208
@NP	Data for five preparations	27221
@NP	Data	27221
@NP	five preparations	27230
@NP	Fig. 2 .	27256
@NP	Fig.	27256
@NP	2	27261
@NP	Disparity	27264
@NP	distribution	27282
@NP	transplanted Hoechst-labeled and lentivirally-transfected primate OEG	27298
@NP	transplanted Hoechst-labeled	27298
@NP	transplanted	27298
@NP	lentivirally-transfected primate OEG	27331
@NP	A , B.	27369
@NP	A	27369
@NP	B.	27371
@NP	Phase contrast and fluorescence images of a culture of p75	27374
@NP	Phase contrast and fluorescence images	27374
@NP	a culture of p75	27416
@NP	a culture	27416
@NP	p75	27429
@NP	primate cells exposed to the eGFP lentiviral vector for 48 h	27448
@NP	primate cells	27448
@NP	the eGFP lentiviral vector for 48 h	27473
@NP	the eGFP lentiviral vector	27473
@NP	48 h	27504
@NP	a high rate of transfection	27514
@NP	a high rate	27514
@NP	transfection	27529
@NP	C.	27543
@NP	The transection site -LRB- arrow -RRB-	27546
@NP	The transection site	27546
@NP	arrow	27568
@NP	characteristic excellent healing between the stumps	27589
@NP	characteristic excellent healing	27589
@NP	the stumps	27630
@NP	D.	27642
@NP	Hoechst-positive cells within the central canal	27645
@NP	Hoechst-positive cells	27645
@NP	the central canal	27675
@NP	a frequent finding	27698
@NP	E.	27718
@NP	Hoechst-labeled POEG-derived cells exposed to GFP lentiviral vector for 48 h	27721
@NP	Hoechst-labeled POEG-derived cells	27721
@NP	GFP lentiviral vector for 48 h	27767
@NP	GFP lentiviral vector	27767
@NP	48 h	27793
@NP	the spinal cord stumps	27821
@NP	the animal	27853
@NP	42 days	27883
@NP	40 μm thick sagittal sections	27892
@NP	40 μm	27892
@NP	Migration of the lentiviral cells	27932
@NP	Migration	27932
@NP	the lentiviral cells	27945
@NP	the transection gap	28002
@NP	the pial surface	28029
@NP	nerve roots	28055
@NP	white box , right side magnified in the right corner inset	28068
@NP	white box	28068
@NP	right side magnified in the right corner inset	28079
@NP	right side	28079
@NP	the right corner inset	28103
@NP	The Hoechst-positive region	28128
@NP	the GFP-positive region and Hoechst-positive cells	28172
@NP	the GFP-positive region	28172
@NP	Hoechst-positive cells	28200
@NP	rostral in the central canal -LRB- white box , left -RRB-	28233
@NP	rostral	28233
@NP	the central canal -LRB- white box , left -RRB-	28244
@NP	the central canal	28244
@NP	white box , left	28263
@NP	white box	28263
@NP	GFP	28285
@NP	the characteristic microcavitation	28304
@NP	the spinal cord stumps	28346
@NP	Bar	28370
@NP	0.8 mm	28374
@NP	Fig. 3 .	28383
@NP	Fig.	28383
@NP	3	28388
@NP	POEG-transplanted animals	28391
@NP	superior behavioral recovery	28422
@NP	A.	28452
@NP	BBB scores	28455
@NP	OEG-transplanted -LRB- open triangles -RRB- and media-transplanted	28469
@NP	OEG-transplanted -LRB- open triangles -RRB-	28469
@NP	media-transplanted	28507
@NP	boxes	28534
@NP	1 to 20 weeks	28546
@NP	spinal cord transection	28570
@NP	= pb0 .01 , = pb0 .001 .	28597
@NP	= pb0 .01	28597
@NP	= pb0 .001	28609
@NP	Data from the subset of lentivirally-transfected OEC	28619
@NP	Data	28619
@NP	the subset of lentivirally-transfected OEC	28629
@NP	the subset	28629
@NP	lentivirally-transfected OEC	28643
@NP	the right BBB scores	28694
@NP	a subset of OEGtransplanted animals pre	28718
@NP	a subset	28718
@NP	OEGtransplanted animals pre	28730
@NP	OEGtransplanted animals	28730
@NP	retransection	28768
@NP	B.	28792
@NP	Four representative digital video frames	28795
@NP	a transplanted animal in the open field	28839
@NP	a transplanted animal	28839
@NP	the open field	28864
@NP	A weight-supported step	28880
@NP	Video	28914
@NP	37 frames per second	28936
@NP	37 frames	28936
@NP	second	28950
@NP	every fourth frame	28961
@NP	supplemental video	28995
@NP	POEG17 BBB	29014
@NP	POEG17	29014
@NP	BBB	29021
@NP	C.	29027
@NP	A media-injected control animal	29030
@NP	the wire mesh ramp	29081
@NP	75 degrees	29103
@NP	every fourth frame	29121
@NP	supplemental video	29155
@NP	POEG30a ramp	29174
@NP	POEG30a	29174
@NP	ramp	29182
@NP	Fig. 4 .	29190
@NP	Fig.	29190
@NP	4	29195
@NP	Chronic renal injury in spinal transected nude rats .	29198
@NP	Chronic renal injury	29198
@NP	spinal transected nude rats	29222
@NP	The kidneys	29251
@NP	ureters	29264
@NP	bladder from 2 nude rats with chronic transection and transplantation	29276
@NP	bladder	29276
@NP	2 nude rats with chronic transection and transplantation	29289
@NP	2 nude rats	29289
@NP	chronic transection and transplantation	29306
@NP	A.	29360
@NP	the bladder	29363
@NP	evidence of distension	29379
@NP	evidence	29379
@NP	distension	29391
@NP	soft and firm masses that consisted of calcium carbonate and oxalate	29415
@NP	soft and firm masses	29415
@NP	calcium carbonate and oxalate	29454
@NP	B.	29488
@NP	The kidneys	29491
@NP	the calyces with cortical and medullary scarring	29520
@NP	the calyces	29520
@NP	cortical and medullary scarring	29537
@NP	This	29570
@NP	chronic pyelonephritis and renal calculi formation	29594
@NP	Scale marker = mm .	29646
@NP	Scale	29646
@NP	marker = mm	29652
@NP	demarcations .	29663
@NP	Renal system injury scores .	29677
@NP	Renal system	29677
@NP	injury scores	29690
@NP	A calculi	29708
@NP	the bladder and kidney -LRB- 2 -RRB- but renal parenchymal damage	29737
@NP	the bladder and kidney -LRB- 2 -RRB-	29737
@NP	the bladder and kidney	29737
@NP	2	29761
@NP	renal parenchymal damage	29768
@NP	minimal -LRB- 0 -RRB- , total score = 2	29796
@NP	minimal	29796
@NP	0	29805
@NP	total score = 2	29809
@NP	total score	29809
@NP	2	29821
@NP	B	29827
@NP	calculi	29829
@NP	both the bladder and kidneys -LRB- 2 -RRB-	29857
@NP	the bladder	29862
@NP	kidneys -LRB- 2 -RRB-	29878
@NP	kidneys	29878
@NP	2	29887
@NP	the renal parenchymal injury	29894
@NP	severe -LRB- 3 -RRB- , total score = 5	29926
@NP	-LRB- 3 -RRB- , total score = 5	29933
@NP	, total score	29936
@NP	5	29950
@NP	Fig. 5 .	29954
@NP	Fig.	29954
@NP	5	29959
@NP	Serotonergic fiber regeneration .	29962
@NP	Serotonergic fiber	29962
@NP	regeneration	29981
@NP	A.	29995
@NP	Anti-5-HT immunostaining	29998
@NP	the spinal cord six months	30026
@NP	the spinal cord	30026
@NP	six months	30042
@NP	OEG transplantation	30059
@NP	A representative animal with fairly severe cavitation	30080
@NP	A representative animal	30080
@NP	fairly severe cavitation	30109
@NP	the transection site	30146
@NP	this cavitation	30185
@NP	there	30202
@NP	no die-back of 5-HT fibers	30211
@NP	no die-back	30211
@NP	5-HT fibers	30226
@NP	a considerable number of sprouts	30242
@NP	a considerable number	30242
@NP	sprouts	30267
@NP	the cavities and at the margin of the transection site	30299
@NP	the cavities	30299
@NP	the margin	30319
@NP	the transection site	30333
@NP	Rostral	30355
@NP	the left	30369
@NP	B.	30379
@NP	region of central box	30392
@NP	region	30392
@NP	central box	30402
@NP	A.	30417
@NP	A lengthy fiber	30420
@NP	the distal spinal cord stump	30469
@NP	C.	30499
@NP	region of distal box	30512
@NP	region	30512
@NP	distal box	30522
@NP	A.	30536
@NP	A fiber	30539
@NP	the distal end of the section , a distance of 7.1 cm	30564
@NP	the distal end	30564
@NP	the section , a distance of 7.1 cm	30582
@NP	the section	30582
@NP	a distance of 7.1 cm	30595
@NP	a distance	30595
@NP	7.1 cm	30609
@NP	Bar	30617
@NP	2.5 mm	30621
@NP	Fig. 6 .	30630
@NP	Fig.	30630
@NP	6	30635
@NP	Anterogradely-labeled CST images .	30638
@NP	Anterogradely-labeled CST	30638
@NP	images	30664
@NP	A.	30672
@NP	A Neurolucida photomontage	30675
@NP	a transected spinal cord segment	30705
@NP	the composite anterograde BDA label from 12 sections	30749
@NP	the composite anterograde BDA label	30749
@NP	12 sections	30790
@NP	Bar	30821
@NP	2 mm	30825
@NP	B.	30831
@NP	Bilateral labeling	30834
@NP	the cerebral cortex of the nude rat used for A.	30856
@NP	the cerebral cortex	30856
@NP	the nude rat used for A.	30879
@NP	the nude rat	30879
@NP	A.	30901
@NP	C.	30904
@NP	CST label in the medulla of the same animal .	30907
@NP	CST label	30907
@NP	the medulla	30920
@NP	the same animal	30935
@NP	D.	30952
@NP	Collateral branches emerging from rostral intact CST fibers ,	30955
@NP	Collateral branches	30955
@NP	rostral intact CST fibers	30989
@NP	100 μm	31020
@NP	Fig. 7 .	31029
@NP	Fig.	31029
@NP	7	31034
@NP	Transmission electron micrographs .	31037
@NP	Transmission	31037
@NP	electron micrographs	31050
@NP	A.	31072
@NP	the lesion site of an animal transplanted with OEG -LRB- 6600 × -RRB-	31080
@NP	the lesion site	31080
@NP	an animal transplanted with OEG	31099
@NP	an animal transplanted	31099
@NP	OEG	31127
@NP	6600 ×	31132
@NP	Cells with dark cytoplasm	31140
@NP	Cells	31140
@NP	dark cytoplasm	31151
@NP	ensheath	31178
@NP	myelinate axons in this fascicle	31198
@NP	myelinate axons	31198
@NP	this fascicle	31217
@NP	The ensheathment	31232
@NP	Schwann cells	31274
@NP	Basal lamina	31289
@NP	the outer membrane surfaces -LRB- black arrow -RRB-	31316
@NP	the outer membrane surfaces	31316
@NP	black arrow	31345
@NP	The fascicle	31359
@NP	a typical perineurial cellular process -LRB- white arrow -RRB-	31389
@NP	a typical perineurial cellular process	31389
@NP	white arrow	31429
@NP	B.	31443
@NP	the proximal stump , lesion site interface -LRB- 9500 × -RRB-	31451
@NP	the proximal stump , lesion site interface	31451
@NP	9500 ×	31494
@NP	An large axon with thick peripheral myelin -LRB- white asterisk -RRB-	31502
@NP	An large axon	31502
@NP	thick peripheral myelin -LRB- white asterisk -RRB-	31521
@NP	several astrocyte processes and unmyelinated axons	31594
@NP	several astrocyte processes	31594
@NP	unmyelinated axons	31626
@NP	A cell with thin strands of dark cytoplasm	31646
@NP	A cell	31646
@NP	thin strands of dark cytoplasm	31658
@NP	thin strands	31658
@NP	dark cytoplasm	31674
@NP	small axons	31708
@NP	the presence of microtubules , dark asterisk	31735
@NP	the presence	31735
@NP	microtubules , dark asterisk	31751
@NP	microtubules	31751
@NP	dark asterisk	31765
@NP	contacts astrocyte	31789
@NP	basal lamina -LRB- white arrow -RRB-	31843
@NP	basal lamina	31843
@NP	white arrow	31857
@NP	C.	31871
@NP	The cell with thin	31874
@NP	The cell	31874
@NP	dark cytoplasm	31902
@NP	zonula-type junctions with astrocyte processes -LRB- small asterisk -RRB-	31921
@NP	zonula-type junctions	31921
@NP	astrocyte processes -LRB- small asterisk -RRB-	31948
@NP	astrocyte processes	31948
@NP	small asterisk	31969
@NP	These junctions	31985
@NP	those	32016
@NP	the astrocyte processes -LRB- large asterisk -RRB-	32047
@NP	the astrocyte processes	32047
@NP	large asterisk	32072
@NP	the 57 animals in the study	32093
@NP	the 57 animals	32093
@NP	the study	32111
@NP	Five transplanted and four control animals	32122
@NP	Five transplanted	32122
@NP	four control animals	32144
@NP	the end-point	32179
@NP	purposes of histological analysis	32211
@NP	purposes	32211
@NP	histological analysis	32223
@NP	chronic renal damage	32264
@NP	Five other animals	32305
@NP	a minor degree	32334
@NP	autotomy	32352
@NP	Richter	32362
@NP	et al. , 2005	32370
@NP	et al.	32370
@NP	2005	32378
@NP	1	32393
@NP	a control injection and 4	32399
@NP	a control injection	32399
@NP	4	32423
@NP	OEG injections	32429
@NP	The overall incidence of autotomy	32445
@NP	The overall incidence	32445
@NP	autotomy	32470
@NP	9 %	32483
@NP	The odds ratio transplant : control ,	32487
@NP	The odds ratio transplant	32487
@NP	control	32513
@NP	2.1 which was not statistically significant p = 0.66	32526
@NP	2.1	32526
@NP	statistically significant p = 0.66	32544
@NP	statistically significant p	32544
@NP	0.66	32572
@NP	Cultures	32578
@NP	primate olfactory bulb-derived cells	32590
@NP	A primate olfactory bulb with attached tissues	32627
@NP	A primate olfactory bulb	32627
@NP	attached tissues	32657
@NP	Fig. 1C	32692
@NP	The initial cell yield per gram of dissected primate olfactory bulb	32701
@NP	The initial cell yield	32701
@NP	gram of dissected primate olfactory bulb	32728
@NP	gram	32728
@NP	dissected primate olfactory bulb	32736
@NP	8000 + / − 3000 cells per mg starting tissue	32773
@NP	8000 +	32773
@NP	− 3000 cells per mg	32779
@NP	− 3000 cells	32779
@NP	mg	32795
@NP	tissue	32807
@NP	Immunopanning	32815
@NP	the percent p75	32855
@NP	positive cells from 43 % ± 11 % pre-panning	32871
@NP	positive cells	32871
@NP	43 % ± 11 % pre-panning	32891
@NP	43 %	32891
@NP	± 11 %	32894
@NP	85 % ± 9 % post-panning -LRB- Fig. 1D -RRB-	32914
@NP	85 % ± 9 % post-panning	32914
@NP	85 %	32914
@NP	± 9 %	32917
@NP	Fig. 1D	32935
@NP	two distinctive morphologies of primate OEG	32945
@NP	two distinctive morphologies	32945
@NP	primate OEG	32977
@NP	a spindly Schwann cell-like -LRB- Fig. 1A , B -RRB-	33004
@NP	a spindly Schwann	33004
@NP	cell-like -LRB- Fig. 1A , B -RRB-	33022
@NP	cell-like	33022
@NP	Fig. 1A , B	33033
@NP	a flatter `` astrocyte-like '' appearance -LRB- Fig. 1A , B. -RRB-	33047
@NP	a flatter	33047
@NP	`` astrocyte-like '' appearance -LRB- Fig. 1A , B. -RRB-	33057
@NP	`` astrocyte-like '' appearance	33057
@NP	Fig. 1A	33086
@NP	B.	33093
@NP	The latter	33097
@NP	other investigators	33130
@NP	rodent cells	33159
@NP	van den Pol and Santarelli	33173
@NP	van den Pol	33173
@NP	Santarelli	33189
@NP	2003 ; Vincent et al. , 2003	33201
@NP	2003	33201
@NP	Vincent et al. , 2003	33207
@NP	Vincent	33207
@NP	et al. , 2003	33215
@NP	et al.	33215
@NP	2003	33223
@NP	the current study	33233
@NP	these	33252
@NP	astrocyte-like cells	33259
@NP	S-100	33294
@NP	some	33310
@NP	p75	33320
@NP	others	33337
@NP	immunopanning	33368
@NP	p75 immunopanning	33424
@NP	these cells	33458
@NP	Anti-p75 immunopanning performed at seven days	33471
@NP	Anti-p75 immunopanning	33471
@NP	seven days	33507
@NP	a considerable overall cell loss	33530
@NP	Fig. 1D	33581
@NP	This cell loss	33590
@NP	it	33610
@NP	the cell culture	33633
@NP	an additional two to three weeks	33654
@NP	sufficient cells	33706
@NP	transplantation	33727
@NP	Graft composition The composition and viability of the cellular transplants	33744
@NP	Graft composition The composition	33744
@NP	Graft composition	33744
@NP	The composition	33762
@NP	viability of the cellular transplants	33782
@NP	viability	33782
@NP	the cellular transplants	33795
@NP	completion of the transplantation procedure	33838
@NP	completion	33838
@NP	the transplantation procedure	33852
@NP	an aliquot of the cellular suspension	33893
@NP	an aliquot	33893
@NP	the cellular suspension	33907
@NP	the Hamilton syringe	33936
@NP	a collagen-coated Aclar hat	33962
@NP	This	33991
@NP	assessment	34004
@NP	p75 positive cell survival	34018
@NP	the suspension preparation	34055
@NP	maintenance on ice for approximately 2.5 h	34083
@NP	maintenance	34083
@NP	ice for approximately 2.5 h	34098
@NP	ice	34098
@NP	approximately 2.5 h	34106
@NP	injection	34131
@NP	the 33 gauge needle	34149
@NP	Itwas	34170
@NP	9 -- 14 % of the total cells	34187
@NP	9 -- 14 %	34187
@NP	9	34187
@NP	the total cells	34196
@NP	viable -LRB- did not exclude trypan blue -RRB-	34221
@NP	viable	34221
@NP	trypan blue	34245
@NP	preparation and extrusion	34264
@NP	the syringe	34295
@NP	The transplanted cellular suspensions varied from 83	34308
@NP	The transplanted cellular suspensions	34308
@NP	83	34358
@NP	96 % p75	34361
@NP	96 %	34361
@NP	p75	34365
@NP	other experiments	34382
@NP	our laboratory	34400
@NP	almost all of the non-p75 positive cells	34434
@NP	almost all	34434
@NP	the non-p75 positive cells	34448
@NP	fibronectin-positive putative fibroblasts -LRB- J.	34479
@NP	fibronectin-positive putative fibroblasts	34479
@NP	J.	34522
@NP	Guest , unpublished data -RRB-	34525
@NP	Guest	34525
@NP	data	34544
@NP	such cells	34562
@NP	many as 4 -- 17 % of the cells in the transplant	34595
@NP	many as 4	34595
@NP	17 % of the cells in the transplant	34605
@NP	17 %	34605
@NP	the cells in the transplant	34612
@NP	the cells	34612
@NP	the transplant	34625
@NP	No clear relationship	34641
@NP	primate donor age or sex and the cell yields or final p75 purity	34679
@NP	primate donor age or sex	34679
@NP	primate donor age	34679
@NP	sex	34700
@NP	the cell yields or final p75 purity	34708
@NP	the cell yields	34708
@NP	final p75 purity	34727
@NP	GFAP positive astrocytes	34745
@NP	the transplanted cellular suspensions	34788
@NP	Transfection of	34827
@NP	Transfection	34827
@NP	POEG	34852
@NP	lentivirus Transfection of p75 purified primate OEG cultures with pLenti6	34862
@NP	lentivirus Transfection	34862
@NP	p75 purified primate OEG cultures with pLenti6	34889
@NP	p75	34889
@NP	primate OEG cultures	34902
@NP	pLenti6	34928
@NP	V5-TOPO/gfp	34937
@NP	an efficiency of transfection of 90 ±	34961
@NP	an efficiency	34961
@NP	transfection of 90 ±	34978
@NP	transfection	34978
@NP	90 ±	34994
@NP	5 % at 48 h using an MOI of 50:1 -LRB- Fig. 2A , B -RRB-	34997
@NP	5 %	34997
@NP	48 h using an MOI of 50:1 -LRB- Fig. 2A , B -RRB-	35003
@NP	48 h	35003
@NP	an MOI of 50:1 -LRB- Fig. 2A , B -RRB-	35014
@NP	an MOI	35014
@NP	50:1 -LRB- Fig. 2A , B -RRB-	35024
@NP	50:1	35024
@NP	Fig. 2A , B	35030
@NP	Fig. 2A	35030
@NP	B	35038
@NP	Behavioral recovery .	35042
@NP	field locomotion	35071
@NP	All animals	35088
@NP	BBB scores of 21	35110
@NP	BBB scores	35110
@NP	21	35124
@NP	pre-training prior	35134
@NP	the transection and injection of cells or control media	35156
@NP	the transection and injection	35156
@NP	cells or control media	35189
@NP	Fig. 3A	35225
@NP	a statistically significant difference in open field locomotor scores	35233
@NP	a statistically significant difference	35233
@NP	open field locomotor scores	35275
@NP	eight weeks	35319
@NP	The BBB scores in both groups	35353
@NP	The BBB scores	35353
@NP	both groups	35371
@NP	12 weeks	35393
@NP	The differences between the two groups	35427
@NP	The differences	35427
@NP	the two groups	35451
@NP	significant at 8 , 10 , 12 , 14 , 16 and 18 weeks	35485
@NP	8 , 10 , 12 , 14 , 16 and 18	35500
@NP	8 weeks	35546
@NP	18 weeks	35563
@NP	The best transplanted animals	35573
@NP	Fig. 3B	35639
@NP	they	35652
@NP	fore-limb	35664
@NP	hind-limb coordination	35677
@NP	postural instability	35705
@NP	an unusual hopping motion -LRB- see supplemental video POEG 17 BBB -RRB-	35741
@NP	an unusual hopping motion	35741
@NP	supplemental video POEG 17 BBB	35772
@NP	POEG 17 BBB	35791
@NP	This	35805
@NP	a BBB score of 11	35825
@NP	a BBB score	35825
@NP	11	35840
@NP	No control animals	35844
@NP	weight-supported stepping during open field testing	35870
@NP	weight-supported	35870
@NP	open field testing	35903
@NP	Five POEG-transplanted rats	35923
@NP	BBB scores	35957
@NP	7 or greater for two successive weeks	35977
@NP	7 or greater	35977
@NP	two successive weeks	35994
@NP	retransection	36025
@NP	T9/10	36042
@NP	one animal	36060
@NP	a marked decline in BBB scores but the other four did not -LRB- Fig. 3A -RRB-	36078
@NP	a marked decline	36078
@NP	BBB scores but the other four did not -LRB- Fig. 3A -RRB-	36098
@NP	BBB scores but the other four did not	36098
@NP	the other four	36113
@NP	Fig. 3A	36137
@NP	Mean pre-retransection scores	36147
@NP	7.4 + / − 0.55 SD	36182
@NP	7.4 +	36182
@NP	− 0.55	36187
@NP	SD	36193
@NP	post-retransection scores	36205
@NP	6.2 + / − 1.9 SD	36236
@NP	6.2 +	36236
@NP	− 1.9	36241
@NP	SD	36246
@NP	Paired t-test p value = 0.21 .	36250
@NP	Paired t-test p value	36250
@NP	The BBB scores of the animals transplanted with lentivirally-transfected cells	36278
@NP	The BBB scores	36278
@NP	the animals transplanted with lentivirally-transfected cells	36296
@NP	the animals	36296
@NP	lentivirally-transfected cells	36326
@NP	those transplanted with non-transfected cells	36382
@NP	those	36382
@NP	non-transfected cells	36406
@NP	the difference	36433
@NP	Behavioral recovery .	36481
@NP	B	36502
@NP	Ascent of a wire mesh ramp All animals	36506
@NP	Ascent	36506
@NP	a wire mesh ramp All animals	36516
@NP	a wire mesh ramp	36516
@NP	All animals	36533
@NP	some degree of stepping locomotor activity on the ramp at 45 degrees	36555
@NP	some degree	36555
@NP	locomotor activity	36579
@NP	the ramp at 45 degrees	36601
@NP	the ramp	36601
@NP	45 degrees	36613
@NP	Both the transected control-injected animals and transplanted rats	36625
@NP	Both the transected control-injected animals	36625
@NP	transplanted rats	36674
@NP	motions and ascent of the grid at 60 degrees -LRB- Fig. 3C -RRB-	36711
@NP	motions and ascent	36711
@NP	the grid at 60 degrees -LRB- Fig. 3C -RRB-	36733
@NP	the grid	36733
@NP	60 degrees -LRB- Fig. 3C -RRB-	36745
@NP	60 degrees	36745
@NP	Fig. 3C	36757
@NP	Interestingly these stepping movementswere	36767
@NP	animals	36827
@NP	no	36850
@NP	the open field -LRB- see supplemental video POEG30a ramp and POEG30a BBB -RRB-	36865
@NP	the open field	36865
@NP	supplemental video POEG30a ramp and POEG30a BBB	36885
@NP	supplemental video POEG30a ramp	36885
@NP	POEG30a BBB	36921
@NP	The animals	36935
@NP	clonic posterior limb spasms	36962
@NP	the grid	37000
@NP	Therewas	37010
@NP	no statistically significant difference	37019
@NP	the angle	37067
@NP	POEG-transplanted 63 ± 9.5 and control media-injected rats 54 ± 10.5	37086
@NP	POEG-transplanted 63 ± 9.5	37086
@NP	POEG-transplanted 63	37086
@NP	± 9.5	37106
@NP	control media-injected rats 54 ± 10.5	37115
@NP	control media-injected rats	37115
@NP	54 ± 10.5	37143
@NP	movements and ascent of the grid , Student 's 2-tailed test	37170
@NP	movements and ascent	37170
@NP	the grid , Student 's 2-tailed test	37194
@NP	the grid	37194
@NP	Student 's 2-tailed test	37204
@NP	Student 's	37204
@NP	p = 0.06	37229
@NP	p	37229
@NP	0.06	37231
@NP	Correlation of renal pathology with BBB	37237
@NP	Correlation	37237
@NP	renal pathology with BBB	37252
@NP	renal pathology	37252
@NP	BBB	37273
@NP	scores	37277
@NP	autopsy examination of the renal system	37287
@NP	autopsy examination	37287
@NP	the renal system	37310
@NP	all animals	37327
@NP	some evidence of chronic bladder distension and renal calculi formation	37346
@NP	some evidence	37346
@NP	chronic bladder distension and renal calculi formation	37363
@NP	Fig. 4A , B	37419
@NP	Fig. 4A	37419
@NP	B	37427
@NP	most animals	37434
@NP	no other organ system	37447
@NP	notable pathology	37476
@NP	three animals	37506
@NP	interstitial pneumonia	37520
@NP	lung histology	37563
@NP	The main differences between animals	37579
@NP	The main differences	37579
@NP	animals	37608
@NP	examination	37631
@NP	the kidneys for evidence of chronic pyelonephritis -LRB- Fig. 4A versus B -RRB-	37646
@NP	the kidneys	37646
@NP	evidence of chronic pyelonephritis -LRB- Fig. 4A versus B -RRB-	37662
@NP	evidence	37662
@NP	chronic pyelonephritis -LRB- Fig. 4A versus B -RRB-	37674
@NP	chronic pyelonephritis	37674
@NP	Fig. 4A versus B	37698
@NP	Fig. 4A	37698
@NP	B	37713
@NP	The mean	37717
@NP	renal pathology score for control animalswas	37726
@NP	renal pathology score	37726
@NP	control animalswas	37752
@NP	2.75 ± 1.1 and for transplantswas	37771
@NP	2.75	37771
@NP	transplantswas	37788
@NP	3.0 ± 1.2	37803
@NP	3.0	37803
@NP	± 1.2	37806
@NP	Student 's 2 tailed t-test , p = 0.58 -RRB-	37813
@NP	Student 's	37813
@NP	2	37823
@NP	t-test , p = 0.58	37832
@NP	t-test	37832
@NP	p = 0.58	37840
@NP	p	37840
@NP	0.58	37842
@NP	the peak BBB score less the terminal BBB scores	37853
@NP	the peak BBB score	37853
@NP	the terminal BBB scores	37877
@NP	the renal injury score , those of the transplanted animals	37922
@NP	the renal injury score	37922
@NP	those of the transplanted animals	37946
@NP	those	37946
@NP	the transplanted animals	37955
@NP	significant correlation -LRB- Spearman 's test , r = 0.79 , p = .003 -RRB-	37999
@NP	significant correlation	37999
@NP	Spearman 's test , r = 0.79 , p = .003	38024
@NP	Spearman 's test	38024
@NP	Spearman 's	38024
@NP	r = 0.79	38041
@NP	r	38041
@NP	0.79	38043
@NP	p = .003	38049
@NP	p	38049
@NP	.003	38051
@NP	a relation	38074
@NP	the decrease in BBB scores and the extent of renal pathology in this sample	38093
@NP	the decrease in BBB scores	38093
@NP	the decrease	38093
@NP	BBB scores	38109
@NP	the extent of renal pathology in this sample	38124
@NP	the extent	38124
@NP	renal pathology in this sample	38138
@NP	renal pathology	38138
@NP	this sample	38157
@NP	such a correlation	38186
@NP	control animals -LRB- r = 0.36 , p = 0.25 -RRB-	38222
@NP	control animals	38222
@NP	r = 0.36 , p = 0.25	38239
@NP	r	38239
@NP	= 0.36 , p = 0.25	38240
@NP	= 0.36 , p	38240
@NP	0.36	38241
@NP	0.25	38249
@NP	this discrepancy	38264
@NP	fact	38304
@NP	the control animals	38314
@NP	the same degree of BBB	38347
@NP	the same degree	38347
@NP	BBB	38366
@NP	recovery	38376
@NP	the absolute value of peak minus terminal scores	38389
@NP	the absolute value	38389
@NP	peak minus terminal scores	38411
@NP	peak	38411
@NP	terminal scores	38422
@NP	Mineral analysis of urinary stones found within the bladder and kidneys	38457
@NP	Mineral analysis	38457
@NP	urinary stones found within the bladder and kidneys	38477
@NP	urinary stones	38477
@NP	the bladder and kidneys	38505
@NP	the bladder	38505
@NP	kidneys	38521
@NP	large concretions of magnesium ammonium phosphate and calcium carbonate	38540
@NP	large concretions	38540
@NP	magnesium ammonium phosphate and calcium carbonate	38561
@NP	magnesium ammonium phosphate	38561
@NP	calcium carbonate	38594
@NP	Urinary cultures	38613
@NP	E. coli andMorganella morgani	38648
@NP	control animals	38696
@NP	stone composition	38730
@NP	bacterial organisms	38762
@NP	Histological assessment All perfused spinal cords	38783
@NP	Histological assessment	38783
@NP	All perfused spinal cords	38807
@NP	completeness of transection	38886
@NP	completeness	38886
@NP	transection	38902
@NP	each animal	38918
@NP	there	38930
@NP	a complete absence of visible spinal cord	38940
@NP	a complete absence	38940
@NP	visible spinal cord	38962
@NP	a gap filled by scar tissue as seen in Fig. 2C	38986
@NP	a gap	38986
@NP	scar tissue	39002
@NP	Fig. 2C	39025
@NP	Meticulous surgical technique and closure of the dura	39034
@NP	Meticulous surgical technique	39034
@NP	closure of the dura	39068
@NP	closure	39068
@NP	the dura	39079
@NP	the length	39107
@NP	the inter-stump scar -LRB- Zhang et al. , 2004 -RRB-	39121
@NP	the inter-stump scar	39121
@NP	Zhang	39143
@NP	et al. , 2004	39149
@NP	et al.	39149
@NP	2004	39157
@NP	cavities were seen in both control-injected	39167
@NP	cavities	39167
@NP	transplanted animals -LRB- Verdu et al. , 2003 -RRB-	39215
@NP	transplanted animals	39215
@NP	Verdu	39237
@NP	et al. , 2003	39243
@NP	et al.	39243
@NP	2003	39251
@NP	Fig. 5A	39258
@NP	Previous investigators	39268
@NP	OEG	39311
@NP	the spinal cord stump	39328
@NP	the transection site	39355
@NP	This questionwas	39377
@NP	six animals	39407
@NP	the intracellular labels GFP	39427
@NP	Hoechst	39460
@NP	Hoechstpositive cellswere	39488
@NP	the scar tissue of the transection site	39523
@NP	the scar tissue	39523
@NP	the transection site	39542
@NP	the central canal -LRB- Fig. 2D , E -RRB-	39570
@NP	the central canal	39570
@NP	Fig. 2D , E	39589
@NP	Fig. 2D	39589
@NP	E	39597
@NP	the pia mater	39604
@NP	the spinal cord within 5 mm of the transection site	39625
@NP	the spinal cord	39625
@NP	5 mm of the transection site	39648
@NP	5 mm	39648
@NP	the transection site	39656
@NP	The finding	39678
@NP	Hoechst-positive cells within the central canal and on the pia mater	39693
@NP	Hoechst-positive cells	39693
@NP	the central canal	39723
@NP	the pia mater	39748
@NP	the extent ofGFP-labeled cells	39792
@NP	the extent	39792
@NP	ofGFP-labeled cells	39803
@NP	considerably fromthat of the Hoechst-labeled cells	39832
@NP	considerably fromthat	39832
@NP	the Hoechst-labeled cells	39857
@NP	the Hoechst-positive cells in the central canal	39892
@NP	the Hoechst-positive cells	39892
@NP	the central canal	39922
@NP	Fig. 2E	39963
@NP	Many GFP-positive cells	39973
@NP	spinal nerve roots	40016
@NP	an elongated morphology -LRB- Fig. 2E -RRB-	40046
@NP	an	40046
@NP	morphology -LRB- Fig. 2E -RRB-	40059
@NP	morphology	40059
@NP	Fig. 2E	40071
@NP	the cells	40089
@NP	the nerve root environment	40118
@NP	unpublished data	40146
@NP	A large number	40165
@NP	macrophageswere present in the transection site at sixweeks and many of these	40183
@NP	macrophageswere present in the transection site at sixweeks	40183
@NP	macrophageswere present in the transection site	40183
@NP	the transection	40210
@NP	sixweeks	40234
@NP	many of these	40247
@NP	many	40247
@NP	these	40255
@NP	GFP indicating considerable death or engulfment of the transplanted	40297
@NP	GFP	40297
@NP	considerable death or engulfment of the transplanted	40312
@NP	considerable death or engulfment	40312
@NP	the transplanted	40348
@NP	cells	40377
@NP	14 weeks	40387
@NP	no discernable GFP-positive transplanted cells	40396
@NP	GFP-positive debris in macrophages	40467
@NP	GFP-positive debris	40467
@NP	macrophages	40490
@NP	the anti-human/primate p75 antibody employed in vitro	40536
@NP	the anti-human/primate p75 antibody	40536
@NP	the fixed tissue of xenografted animals	40610
@NP	the fixed tissue	40610
@NP	xenografted animals	40630
@NP	xenograft survival or cell migration	40679
@NP	it	40720
@NP	knowif cell death or loss of transgene expression accounts	40739
@NP	knowif cell death or loss	40739
@NP	transgene expression accounts	40768
@NP	this observation	40802
@NP	the appearance of the GFP debris	40829
@NP	the appearance	40829
@NP	the GFP debris	40847
@NP	cell death	40881
@NP	5-HT immunostaining Serial sequential 10 μm sagittal or coronal sections	40893
@NP	10	40931
@NP	eleven POEG-transplanted and seven control rats	40971
@NP	eleven POEG-transplanted	40971
@NP	seven control rats	41000
@NP	Indistinct fibers and those less than 100 μm	41033
@NP	Indistinct fibers	41033
@NP	those less than 100 μm	41055
@NP	9	41099
@NP	11 POEG	41108
@NP	animals	41124
@NP	some extension of 5-HT positive processes	41132
@NP	some extension	41132
@NP	5-HT positive processes	41150
@NP	the lesion site	41193
@NP	6	41216
@NP	11 animals	41225
@NP	a few immunolabeled processes	41236
@NP	the distal spinal cord	41289
@NP	These fibers	41313
@NP	the grey matter -LRB- Fig. 5C -RRB-	41350
@NP	the grey matter	41350
@NP	Fig. 5C	41367
@NP	the pia mater at the spinal cord surface	41388
@NP	the pia mater	41388
@NP	the spinal cord surface	41405
@NP	The greatest distance	41430
@NP	a labeled processwas	41461
@NP	the transection sitewas 6.2 mm -LRB- Fig. 5A , C -RRB-	41501
@NP	the transection sitewas 6.2 mm	41501
@NP	Fig. 5A , C	41531
@NP	Fig. 5A	41531
@NP	C	41539
@NP	most of the processes	41551
@NP	most	41551
@NP	the processes	41559
@NP	more than 1 mm	41588
@NP	the distal spinal cord stump -LRB- Fig. 5A -RRB-	41608
@NP	the distal spinal cord stump	41608
@NP	Fig. 5A	41638
@NP	The mean number of 5-HT positive fibers	41648
@NP	The mean number	41648
@NP	5-HT positive fibers	41667
@NP	the transection site	41707
@NP	the 10 contiguous sections with the densest proximal 5-HT	41731
@NP	the 10 contiguous sections	41731
@NP	the densest proximal 5-HT	41763
@NP	21 + / − 11 fibers	41802
@NP	21 +	41802
@NP	− 11 fibers	41806
@NP	−	41806
@NP	11 fibers	41807
@NP	There	41818
@NP	no regeneration of 5-HT positive axons in control animals	41828
@NP	no regeneration	41828
@NP	5-HT positive axons in control animals	41847
@NP	5-HT positive axons	41847
@NP	control animals	41870
@NP	minimal die-back of the tract	41890
@NP	minimal die-back	41890
@NP	the tract	41910
@NP	condition	41943
@NP	No evidence of incomplete transection	41954
@NP	No evidence	41954
@NP	incomplete transection	41969
@NP	any section	42007
@NP	both the BBB analysis and the 5HT immunostaining analysis	42026
@NP	the BBB analysis	42031
@NP	the 5HT immunostaining analysis	42052
@NP	the number of 5-HT	42103
@NP	the number	42103
@NP	5-HT	42117
@NP	positive fibers distal to the transection site	42122
@NP	positive fibers	42122
@NP	the transection site	42148
@NP	the peak BBB scores of the rats	42189
@NP	the peak BBB scores	42189
@NP	the rats	42212
@NP	No significant correlation	42222
@NP	r2 0.02 , p	42263
@NP	r2 0.02	42263
@NP	p	42272
@NP	0.68	42274
@NP	BDA anterograde labeling	42280
@NP	the CST Ten POEG-transplanted and six control animals	42308
@NP	CST Ten	42312
@NP	six	42342
@NP	the CST	42388
@NP	the cortex -LRB- Fig. 6B -RRB- and upper pyramidwere	42412
@NP	the cortex -LRB- Fig. 6B -RRB-	42412
@NP	the cortex	42412
@NP	Fig. 6B	42424
@NP	upper pyramidwere	42437
@NP	BDA	42467
@NP	reaction product -LRB- Fig. 6C -RRB-	42471
@NP	reaction product	42471
@NP	Fig. 6C	42489
@NP	nor	42527
@NP	control animals	42531
@NP	evidence of CST fiber regeneration	42551
@NP	evidence	42551
@NP	CST fiber regeneration	42563
@NP	the lesion site	42601
@NP	no animalwas evidence of incomplete CST injury observed	42630
@NP	no animalwas evidence	42630
@NP	incomplete CST injury observed	42655
@NP	incomplete CST injury	42655
@NP	this laboratory 's previous experience	42702
@NP	this laboratory 's	42702
@NP	human SC grafts -LRB- Guest et al. , 1997a , b -RRB-	42745
@NP	human SC grafts	42745
@NP	Guest	42762
@NP	et al. , 1997a , b	42768
@NP	et al.	42768
@NP	1997a	42776
@NP	b	42782
@NP	a significant reduction	42785
@NP	die-back	42812
@NP	end-bulbs	42835
@NP	OEGtransplanted rats	42848
@NP	the four month time-point	42872
@NP	Fig. 6A	42912
@NP	Evidence of primary collateral formation	42922
@NP	Evidence	42922
@NP	primary collateral formation	42934
@NP	CST fibers within 5mmof the lesion	42980
@NP	CST fibers	42980
@NP	5mmof the lesion	42998
@NP	sitewas also assessed -LRB- Fig. 6D -RRB-	43015
@NP	sitewas also assessed	43015
@NP	sitewas	43015
@NP	Fig. 6D	43038
@NP	A statistically larger number of primary collateral processes	43048
@NP	A statistically larger number	43048
@NP	primary collateral processes	43081
@NP	POEGtransplanted animals -LRB- 1.4 + / − 0.6 processes per axon/mm -RRB-	43123
@NP	POEGtransplanted animals	43123
@NP	1.4 +	43149
@NP	− 0.6 processes per axon/mm	43154
@NP	− 0.6 processes	43154
@NP	axon/mm	43173
@NP	animals -LRB- 0.7 + / − 0.5 processes per axon/mm -RRB- in the 2.5	43205
@NP	animals -LRB- 0.7 + / − 0.5 processes per axon/mm -RRB-	43205
@NP	animals	43205
@NP	0.7 +	43214
@NP	− 0.5 processes per axon/mm	43219
@NP	− 0.5 processes	43219
@NP	axon/mm	43238
@NP	the 2.5	43250
@NP	5.0 mm rostral zone	43259
@NP	p = 0.03 two-tailed Student 's t-test	43280
@NP	p	43280
@NP	= 0.03 two-tailed Student 's t-test	43281
@NP	= 0.03	43281
@NP	two-tailed Student 's t-test	43287
@NP	two-tailed Student 's	43287
@NP	the 0 -- 2.5 mm ; where in fact there were few BDA positive processes at all	43327
@NP	the 0	43327
@NP	2.5 mm ; where in fact there were few BDA positive processes at all	43333
@NP	2.5 mm	43333
@NP	fact	43350
@NP	there	43355
@NP	few BDA positive processes	43366
@NP	Cavity volumes	43401
@NP	The estimated size of spinal cavities	43416
@NP	The estimated size	43416
@NP	spinal cavities	43438
@NP	the transaction region	43466
@NP	from6 .84 mm3	43505
@NP	3.3 mm3	43520
@NP	POEG-transplanted animals	43528
@NP	an average volume	43558
@NP	4.5 + / − 0.77 mm3 as compared to medium injected animals 5.9 + /	43579
@NP	4.5 +	43579
@NP	− 0.77 mm3 as compared to medium injected animals 5.9 +	43584
@NP	− 0.77 mm3	43584
@NP	medium	43609
@NP	animals 5.9 +	43625
@NP	animals	43625
@NP	5.9 +	43633
@NP	− 0.65 mm3	43638
@NP	This difference	43649
@NP	p	43696
@NP	0.01	43698
@NP	Ultrastructure	43704
@NP	Three transplanted animals and three control animals	43719
@NP	Three transplanted animals	43719
@NP	three control animals	43750
@NP	TEM examination of selected regions from the spinal cord stumps and lesion site	43782
@NP	TEM examination	43782
@NP	selected regions from the spinal cord stumps and lesion site	43801
@NP	selected regions	43801
@NP	the spinal cord stumps and lesion site	43823
@NP	the three transplanted animals	43866
@NP	fascicles containing an interesting mixture of ensheathed and myelinated axons	43898
@NP	fascicles	43898
@NP	an interesting mixture of ensheathed and myelinated axons	43919
@NP	an interesting mixture	43919
@NP	ensheathed and myelinated axons	43945
@NP	Fig. 7A	43994
@NP	The cells	44004
@NP	axons	44030
@NP	unusual dark cytoplasm but themyelinating cells	44040
@NP	unusual dark cytoplasm	44040
@NP	themyelinating cells	44067
@NP	this appearance	44101
@NP	control animals	44121
@NP	a small number of fascicles of myelinated axons	44138
@NP	a small number	44138
@NP	fascicles of myelinated axons	44156
@NP	fascicles	44156
@NP	myelinated axons	44169
@NP	none of the cells that were ensheathing	44209
@NP	none	44209
@NP	the cells that were ensheathing	44217
@NP	the cells	44217
@NP	dark cytoplasm	44253
@NP	these cells with dark cytoplasm	44285
@NP	these cells	44285
@NP	dark cytoplasm	44302
@NP	opposed to endogenous in-migrating Schwann cells -LRB- Ramer et al. , 2004 -RRB-	44338
@NP	opposed to endogenous in-migrating Schwann cells	44338
@NP	endogenous in-migrating Schwann	44349
@NP	Ramer	44388
@NP	et al. , 2004	44394
@NP	et al.	44394
@NP	2004	44402
@NP	the pattern of ensheathment	44422
@NP	the pattern	44422
@NP	ensheathment	44437
@NP	that seen with OEGs as compared to SC	44476
@NP	that	44476
@NP	OEGs	44491
@NP	SC	44511
@NP	there	44522
@NP	incomplete and scant cytoplasm around the axons	44531
@NP	incomplete and scant cytoplasm	44531
@NP	the axons	44569
@NP	It	44580
@NP	there	44600
@NP	basal lamina	44610
@NP	the surface of ensheathing cells within this fascicle	44626
@NP	the surface	44626
@NP	ensheathing cells within this fascicle	44641
@NP	ensheathing cells	44641
@NP	this fascicle	44666
@NP	the inner and outer surfaces	44688
@NP	the associated perineurial cells	44720
@NP	the appearance of fascicles of olfactory nerves	44783
@NP	the appearance	44783
@NP	fascicles of olfactory nerves	44801
@NP	fascicles	44801
@NP	olfactory nerves	44814
@NP	the lamina propria and fila olfactoria	44838
@NP	other adult Macaque primates	44880
@NP	our laboratory -LRB- Herrera et al. , 2005 -RRB-	44921
@NP	our laboratory	44921
@NP	Herrera	44937
@NP	et al. , 2005	44945
@NP	et al.	44945
@NP	2005	44953
@NP	Unusual perineurial cellular processes	44960
@NP	other authors -LRB- Li et al. ,1998 ; Boyd et al. , 2004 -RRB-	45022
@NP	other authors	45022
@NP	Li et al. ,1998 ; Boyd et al. , 2004	45037
@NP	Li	45037
@NP	et al. ,1998 ; Boyd et al. , 2004	45040
@NP	et al. ,1998	45040
@NP	et al.	45040
@NP	,1998	45046
@NP	Boyd et al. , 2004	45053
@NP	Boyd	45053
@NP	et al. , 2004	45058
@NP	et al.	45058
@NP	2004	45066
@NP	the OEGtransplanted spinal cord	45075
@NP	many fascicles within the tissue	45117
@NP	many fascicles	45117
@NP	the tissue	45139
@NP	those of peripheral nerve	45160
@NP	those	45160
@NP	peripheral nerve	45169
@NP	novel interactions	45187
@NP	the dark cells , unmyelinated axons , and astrocyte processes	45214
@NP	the dark cells	45214
@NP	unmyelinated axons	45230
@NP	astrocyte processes	45254
@NP	the three transplanted animals	45293
@NP	Fig. 7B	45328
@NP	one of these dark cells	45336
@NP	one	45336
@NP	these dark cells	45343
@NP	a probable Schwann cell	45383
@NP	white asterisk	45408
@NP	several astrocytic processes	45428
@NP	e.g. white arrow	45458
@NP	e.g.	45458
@NP	white arrow	45463
@NP	The cytoplasmic processes of one of these cells	45477
@NP	The cytoplasmic processes	45477
@NP	one of these cells	45506
@NP	one	45506
@NP	these cells	45513
@NP	several small axons -LRB- e.g. black asterisk -RRB-	45553
@NP	several small axons	45553
@NP	e.g. black asterisk	45574
@NP	e.g.	45574
@NP	black asterisk	45579
@NP	the absence of endo - or perineuria	45598
@NP	the absence	45598
@NP	endo - or perineuria	45613
@NP	This cell	45634
@NP	direct contact	45653
@NP	astrocyte processes	45673
@NP	a punctate adhesion-like structure -LRB- Fig. 7C , small asterisk -RRB-	45711
@NP	a punctate adhesion-like structure	45711
@NP	Fig. 7C	45747
@NP	small asterisk	45756
@NP	these membrane appositions	45776
@NP	there	45803
@NP	no visible basal lamina	45812
@NP	Adjacent astrocyte processes	45837
@NP	similar punctate adhesions -LRB- Fig. 7C , large asterisk -RRB-	45871
@NP	similar punctate adhesions	45871
@NP	Fig. 7C	45899
@NP	large asterisk	45908
@NP	This cell 's processes	45925
@NP	This cell 's	45925
@NP	astrocytes	45967
@NP	the glial	45994
@NP	membrane formed in the region of the transection	46013
@NP	membrane	46013
@NP	the region of the transection	46032
@NP	the region	46032
@NP	the transection	46046
@NP	dark arrow	46063
@NP	there	46081
@NP	surface basal lamina associated with these astrocytes	46090
@NP	surface basal lamina	46090
@NP	these astrocytes	46127
@NP	The cytoplasmic continuity of the presumed astroglial cellular processes	46145
@NP	The cytoplasmic continuity	46145
@NP	the presumed astroglial cellular processes	46175
@NP	high quality photomicrographs	46243
@NP	illumination and magnification	46279
@NP	it	46314
@NP	they	46336
@NP	large cells	46354
@NP	extensive intermediate filaments , consistent with reactive astrocytes	46377
@NP	extensive intermediate filaments	46377
@NP	reactive astrocytes	46427
@NP	The cells with dark cytoplasm	46448
@NP	The cells	46448
@NP	dark cytoplasm	46463
@NP	the dense filaments of an astrocyte	46483
@NP	the dense filaments	46483
@NP	an astrocyte	46506
@NP	the dense basal lamina seen on adjacent reactive astrocyte processes	46534
@NP	the dense basal lamina	46534
@NP	adjacent reactive astrocyte processes	46565
@NP	the cells	46612
@NP	dark cytoplasm or direct contacts	46627
@NP	dark cytoplasm	46627
@NP	direct contacts	46645
@NP	ensheathing cells	46669
@NP	astrocyte processes	46691
@NP	animals with medium-only injections	46724
@NP	animals	46724
@NP	medium-only injections	46737
@NP	These observations	48427
@NP	Primate OEGs	48484
@NP	the olfactory bulb	48544
@NP	P75 immunopanningwas	48564
@NP	olfactory bulb-derived cultures	48604
@NP	OEGs	48640
@NP	it	48649
@NP	cultures of predominantly p75 positive cells for at least one	48675
@NP	cultures	48675
@NP	predominantly p75 positive cells for at least one	48687
@NP	predominantly p75 positive cells	48687
@NP	p75	48701
@NP	at least one	48724
@NP	month	48737
@NP	cell loss intrinsic to the immunopanning process	48753
@NP	cell loss	48753
@NP	the immunopanning process	48776
@NP	the time needed to obtain sufficient cells for transplantation	48812
@NP	the time	48812
@NP	sufficient cells	48838
@NP	transplantation	48859
@NP	This finding	48876
@NP	the planning of preclinical studies	48913
@NP	the planning	48913
@NP	preclinical studies	48929
@NP	This	48950
@NP	an autotransplantation paradigm	48989
@NP	even less olfactory tissue	49021
@NP	the primary culture	49071
@NP	our preparations both cadaveric	49095
@NP	our preparations	49095
@NP	cadaveric	49117
@NP	primate olfactory bulbs	49127
@NP	there	49179
@NP	as many as 500,000 cells	49196
@NP	it	49232
@NP	few as 100,000 cells	49253
@NP	the initial cell culture	49289
@NP	a primate autotransplantation	49317
@NP	mitogen expansion	49359
@NP	and approximately threeweeks	49402
@NP	a p75-enriched cell culture -LRB- 106 cells -RRB- for autotransplantation	49457
@NP	a p75-enriched cell culture -LRB- 106 cells -RRB-	49457
@NP	a p75-enriched cell culture	49457
@NP	106 cells	49486
@NP	autotransplantation	49501
@NP	Some investigators	49522
@NP	p75 selection of OEG cell cultures	49554
@NP	p75 selection	49554
@NP	OEG cell cultures	49571
@NP	the efficacy	49600
@NP	a transplanted cell suspension -LRB- Moreno - Flores et al. , 2003 -RRB-	49616
@NP	a transplanted cell suspension	49616
@NP	Moreno	49648
@NP	Flores et al. , 2003	49656
@NP	Flores	49656
@NP	et al.	49663
@NP	2003	49671
@NP	OEG phenotype	49686
@NP	culture conditions	49715
@NP	Franceschini and Barnett , 1996 ; Alexander et al. , 2002 ; Chuah et al. , 2000	49736
@NP	Franceschini and Barnett	49736
@NP	1996 ; Alexander et al. , 2002 ; Chuah et al.	49762
@NP	1996	49762
@NP	Alexander et al. , 2002 ; Chuah et al.	49768
@NP	Alexander	49768
@NP	et al. , 2002 ; Chuah et al.	49778
@NP	et al. , 2002	49778
@NP	et al.	49778
@NP	2002	49786
@NP	Chuah et al.	49792
@NP	Chuah	49792
@NP	et al.	49798
@NP	2000	49806
@NP	future studies	49812
@NP	the impact of culture conditions on OEG survival	49841
@NP	the impact	49841
@NP	culture conditions on OEG survival	49855
@NP	culture conditions	49855
@NP	OEG survival	49877
@NP	migration	49891
@NP	axonal association following transplantation	49906
@NP	an alternative source tissue from which to derive OEG	49958
@NP	an alternative source tissue	49958
@NP	OEG	50008
@NP	the olfactory epithelium	50015
@NP	Au and Roskams	50041
@NP	2003 ; Bianco et al. , 2004 ; Franklin , 2002 ; Lu et al.	50057
@NP	2003	50057
@NP	Bianco et al. , 2004 ; Franklin , 2002 ; Lu et al.	50063
@NP	Bianco	50063
@NP	et al. , 2004 ; Franklin , 2002 ; Lu et al.	50070
@NP	et al. , 2004	50070
@NP	et al.	50070
@NP	2004	50078
@NP	Franklin , 2002	50084
@NP	Franklin	50084
@NP	2002	50094
@NP	Lu et al.	50100
@NP	Lu	50100
@NP	et al.	50103
@NP	2001	50111
@NP	numerous fascicles of SC myelinated axons in the primate lamina propria	50118
@NP	numerous fascicles	50118
@NP	SC myelinated axons in the primate lamina propria	50140
@NP	SC myelinated axons	50140
@NP	the primate lamina propria	50163
@NP	Herrera et al. , 2005	50210
@NP	Herrera	50210
@NP	et al.	50218
@NP	2005	50226
@NP	the extent of our knowledge	50236
@NP	the extent	50236
@NP	our knowledge	50250
@NP	there	50265
@NP	no method to separate SC from OEG	50274
@NP	no method	50274
@NP	separate SC from OEG	50287
@NP	separate SC	50287
@NP	OEG	50304
@NP	they	50313
@NP	similar mitogens -LRB- Yan et al. , 2001 -RRB-	50329
@NP	similar mitogens	50329
@NP	Yan	50347
@NP	et al. , 2001	50351
@NP	et al.	50351
@NP	2001	50359
@NP	This	50366
@NP	purification of OEG	50377
@NP	purification	50377
@NP	OEG	50393
@NP	the primate olfactory epithelium problematic	50402
@NP	the primate olfactory epithelium	50402
@NP	currently available techniques	50453
@NP	A substantial behavioral recovery measured with the BBB test	50488
@NP	A substantial behavioral recovery	50488
@NP	the BBB test	50536
@NP	immune deficient rats that were transplanted with the xenograft cells	50565
@NP	immune deficient rats	50565
@NP	the xenograft cells	50615
@NP	Some studies	50636
@NP	no benefit	50664
@NP	behavioral recovery	50678
@NP	OEG transplantation -LRB- Takami et al. , 2002 ; Resnick et al. , 2003 -RRB-	50708
@NP	OEG transplantation	50708
@NP	Takami	50729
@NP	et al. , 2002 ; Resnick et al. , 2003	50736
@NP	et al.	50736
@NP	2002 ; Resnick et al.	50744
@NP	2002	50744
@NP	Resnick et al.	50750
@NP	Resnick	50750
@NP	et al.	50758
@NP	2003	50766
@NP	these studies	50785
@NP	OEGs	50799
@NP	contusion cavities	50836
@NP	survival	50861
@NP	this study	50897
@NP	transplanted animals	50908
@NP	more locomotor behavioral recovery	50944
@NP	control-injected animals	50984
@NP	limited regeneration of 5-HT axons	51019
@NP	limited regeneration	51019
@NP	5-HT axons	51043
@NP	retransection of the spinal cord in a subset of rats	51068
@NP	retransection	51068
@NP	the spinal cord in a subset of rats	51085
@NP	the spinal cord	51085
@NP	a subset of rats	51104
@NP	a subset	51104
@NP	rats	51116
@NP	loss of the recovery of the hind-limbs	51137
@NP	loss	51137
@NP	the recovery of the hind-limbs	51145
@NP	the recovery	51145
@NP	the hind-limbs	51161
@NP	levels	51187
@NP	BBB scores	51211
@NP	This	51223
@NP	other mechanisms	51242
@NP	long tract regeneration	51277
@NP	the isolated spinal cord	51322
@NP	this recovery	51362
@NP	dorsal column	51387
@NP	injury OECs	51401
@NP	GAP-43	51441
@NP	positive fiber growth	51448
@NP	the distal lesion site -LRB- Andrews and Stelzner , 2007 -RRB-	51475
@NP	the distal lesion site	51475
@NP	Andrews and Stelzner	51499
@NP	2007	51521
@NP	labeled sensory axons	51554
@NP	-LRB- Moreno - Flores et al. , 2006 -RRB-	51577
@NP	Moreno	51578
@NP	Flores et al. , 2006	51586
@NP	Flores	51586
@NP	et al. , 2006	51593
@NP	et	51593
@NP	al.	51596
@NP	CGRP positive sensory fibers -LRB- Richter et al. , 2005 -RRB-	51634
@NP	CGRP	51634
@NP	positive sensory fibers -LRB- Richter et al. , 2005 -RRB-	51639
@NP	positive sensory fibers	51639
@NP	Richter	51664
@NP	et al. , 2005	51672
@NP	et al.	51672
@NP	2005	51680
@NP	It	51686
@NP	distally transplanted OEGs	51706
@NP	sensory afferents	51766
@NP	open field stepping through plasticity of the local stepping circuitry	51799
@NP	open field	51799
@NP	plasticity of the local	51827
@NP	plasticity	51827
@NP	the local	51841
@NP	circuitry	51860
@NP	Behavioral recovery measured with the BBB scale	51874
@NP	Behavioral recovery	51874
@NP	the BBB scale	51908
@NP	time	51942
@NP	Two possible causes for this	51948
@NP	Two possible causes	51948
@NP	this	51972
@NP	death of transplanted cells , and chronic systemic illness	51993
@NP	death of transplanted cells	51993
@NP	death	51993
@NP	transplanted cells	52002
@NP	chronic systemic illness	52026
@NP	GFP-positive POEGs	52052
@NP	14 weeks	52090
@NP	transplantation	52105
@NP	42 days	52141
@NP	There	52150
@NP	little evidence	52159
@NP	studies of cell transplantation for SCI	52180
@NP	studies	52180
@NP	cell transplantation for SCI	52191
@NP	cell transplantation	52191
@NP	SCI	52216
@NP	large numbers	52225
@NP	cells	52242
@NP	transplanted	52248
@NP	the spinal cord	52272
@NP	chronic time points	52291
@NP	Hill et al. , 2007 ; Pearse et al. , 2007 ; Okada et al. , 2005	52312
@NP	Hill	52312
@NP	et al. , 2007 ; Pearse et al. , 2007 ; Okada et al. , 2005	52317
@NP	et al. , 2007	52317
@NP	et al.	52317
@NP	2007	52325
@NP	Pearse et al. , 2007	52331
@NP	Pearse	52331
@NP	et al. , 2007	52338
@NP	et al.	52338
@NP	2007	52346
@NP	Okada et al. , 2005	52352
@NP	Okada	52352
@NP	et al. , 2005	52358
@NP	et al.	52358
@NP	2005	52366
@NP	A delayed cell death	52372
@NP	chronic immune rejection	52409
@NP	other studies	52438
@NP	a decline in behavioral recovery	52464
@NP	a decline	52464
@NP	behavioral recovery	52477
@NP	approximately 40 days	52500
@NP	a this effect -LRB- Jones et al. , 2002 -RRB-	52525
@NP	a this effect	52525
@NP	Jones	52540
@NP	et al. , 2002	52546
@NP	et al.	52546
@NP	2002	52554
@NP	nude rats	52567
@NP	cellular xenografts	52589
@NP	early time points -LRB- Deng et al. , 2006 -RRB-	52612
@NP	early time points	52612
@NP	Deng	52631
@NP	et al. , 2006	52636
@NP	et al.	52636
@NP	2006	52644
@NP	tissue	52654
@NP	several months	52665
@NP	the anterior chamber of the eye -LRB- Bickford - Wimer et al. , 1987 -RRB-	52683
@NP	the anterior chamber	52683
@NP	the eye -LRB- Bickford - Wimer et al. , 1987 -RRB-	52707
@NP	the eye	52707
@NP	Bickford	52716
@NP	Wimer et al. , 1987	52726
@NP	Wimer	52726
@NP	et al.	52732
@NP	1987	52740
@NP	It	52747
@NP	xenograft tolerance of nude rats	52764
@NP	xenograft tolerance	52764
@NP	nude rats	52787
@NP	age -LRB- Maruo et al. ,1982 -RRB-	52813
@NP	age	52813
@NP	Maruo	52818
@NP	et al. ,1982	52824
@NP	et al.	52824
@NP	,1982	52830
@NP	Lentivirus reporter and survival	52837
@NP	Ericson	52871
@NP	et al. , 2002 ; Blits et al. , 2005	52879
@NP	et al.	52879
@NP	2002 ; Blits et al.	52887
@NP	2002	52887
@NP	Blits et al.	52893
@NP	Blits	52893
@NP	et al.	52899
@NP	2005	52907
@NP	The long-term presence of the transplanted cells	52914
@NP	The long-term presence	52914
@NP	the transplanted cells	52940
@NP	trophic or structural effects	52963
@NP	their death	53015
@NP	loss of behavioral gains	53052
@NP	loss	53052
@NP	behavioral gains	53060
@NP	neurocircuitry	53092
@NP	This observation	53108
@NP	implications for CNS xeno	53136
@NP	implications	53136
@NP	CNS xeno	53153
@NP	allo-graft strategies	53170
@NP	the concept	53201
@NP	the short-term presence of the cells	53221
@NP	the short-term presence	53221
@NP	the cells	53248
@NP	a stable remodeling of neurocircuitry	53284
@NP	a stable remodeling	53284
@NP	neurocircuitry	53307
@NP	Long term studies	53323
@NP	the relationship between cell survival and behavioral recovery	53344
@NP	the relationship	53344
@NP	cell survival and behavioral recovery	53369
@NP	cell survival	53369
@NP	behavioral recovery	53387
@NP	Spinal transected nude rats	53419
@NP	chronic renal injury that may limit their utility in long-term SCI experiments	53471
@NP	chronic renal injury	53471
@NP	their utility	53507
@NP	long-term SCI experiments	53524
@NP	The initial plan	53551
@NP	the animals	53581
@NP	one year	53597
@NP	this	53610
@NP	progressive nephropathy and modest weight loss	53639
@NP	the use of chronic antibiotic therapy	53709
@NP	the use	53709
@NP	chronic antibiotic therapy	53720
@NP	previous studies with shorter survival periods	53751
@NP	previous studies	53751
@NP	shorter survival periods	53773
@NP	nude rats	53804
@NP	this problem	53814
@NP	Guest	53848
@NP	et al. , 1997a , b	53854
@NP	et al.	53854
@NP	1997a	53862
@NP	b	53868
@NP	a limitation in the use of nude rats with spinal cord transection	53883
@NP	a limitation	53883
@NP	the use of nude rats with spinal cord transection	53899
@NP	the use	53899
@NP	nude rats with spinal cord transection	53910
@NP	nude rats	53910
@NP	spinal cord transection	53925
@NP	progressive renal damage	53952
@NP	This progressive pathology which appeared to weaken the animals	53978
@NP	This progressive pathology	53978
@NP	the animals	54030
@NP	an alternative explanation	54054
@NP	the degradation of the behavioral recovery	54085
@NP	the degradation	54085
@NP	the behavioral recovery	54104
@NP	A previous study in neurologically intact nude rats -LRB- Miller , 1984 -RRB-	54129
@NP	A previous study	54129
@NP	neurologically intact nude rats -LRB- Miller , 1984 -RRB-	54149
@NP	neurologically intact nude rats	54149
@NP	Miller	54182
@NP	1984	54190
@NP	addition of cyclosporin in the same nude rat strain	54207
@NP	addition	54207
@NP	cyclosporin in the same nude rat strain	54219
@NP	cyclosporin	54219
@NP	the same nude rat strain	54234
@NP	pyelonephritis	54285
@NP	nude rats	54310
@NP	a strong reaction	54325
@NP	foreign tissue antigens	54346
@NP	they	54370
@NP	intact humoral immunity -LRB- Vos et al. , 1980 -RRB-	54389
@NP	intact humoral immunity	54389
@NP	Vos	54414
@NP	et al. , 1980	54418
@NP	et al.	54418
@NP	1980	54426
@NP	Spinal cord injury	54433
@NP	systemic immunosuppressive effects -LRB- Riegger et al. , 2007 -RRB-	54461
@NP	systemic immunosuppressive effects	54461
@NP	Riegger	54497
@NP	et al. , 2007	54505
@NP	et al.	54505
@NP	2007	54513
@NP	the presence of a urinary system compromised by abnormal urine clearance	54528
@NP	the presence	54528
@NP	a urinary system compromised by abnormal urine clearance	54544
@NP	a urinary system	54544
@NP	abnormal urine clearance	54576
@NP	chronic urinary infection	54616
@NP	The possibility	54643
@NP	a systemic infection such as pyelonephritis or pneumonia	54664
@NP	a systemic infection	54664
@NP	pyelonephritis or pneumonia	54693
@NP	the outcome	54744
@NP	therapeutic cell transplantation for SCI	54761
@NP	therapeutic cell transplantation	54761
@NP	SCI	54798
@NP	chronic infection	54830
@NP	an adverse effect	54871
@NP	patients in rehabilitation -LRB- Mylotte et al. , 2001 -RRB-	54892
@NP	patients	54892
@NP	rehabilitation -LRB- Mylotte et al. , 2001 -RRB-	54904
@NP	rehabilitation	54904
@NP	Mylotte	54920
@NP	et al. , 2001	54928
@NP	et al.	54928
@NP	2001	54936
@NP	The control animals	54946
@NP	unexpectedly high scores	54970
@NP	the graded angle gridwalk	54998
@NP	the	54998
@NP	angle gridwalk	55009
@NP	The extent of stepping by the control animals	55025
@NP	The extent	55025
@NP	the control animals	55051
@NP	addition to hind-limb stepping movements during ascent of the gridwalk	55093
@NP	addition	55093
@NP	movements	55124
@NP	ascent of the gridwalk	55141
@NP	ascent	55141
@NP	the gridwalk	55151
@NP	there	55164
@NP	frequent clonic spastic movements of the hind-limbs	55180
@NP	frequent clonic spastic movements	55180
@NP	the hind-limbs	55217
@NP	The graded gridwalk	55233
@NP	The	55233
@NP	gridwalk	55244
@NP	the inclined plane test	55266
@NP	Tator and Rivlin -LRB- Rivlin and Tator , 1977 -RRB-	55312
@NP	Tator and Rivlin	55312
@NP	Rivlin and Tator	55330
@NP	1977	55348
@NP	the surface of the grid	55362
@NP	the surface	55362
@NP	the grid	55377
@NP	only a portion	55393
@NP	each foot to have contact	55411
@NP	contact	55429
@NP	the pressure per unit surface area	55457
@NP	the pressure	55457
@NP	unit surface area	55474
@NP	One possible interpretation	55493
@NP	only a small part of the foot contacts the grid	55537
@NP	only a small part	55537
@NP	the foot contacts the grid	55558
@NP	the foot contacts	55558
@NP	the grid	55576
@NP	there	55586
@NP	a strong activation	55595
@NP	proprioceptive inputs to reflex arcs within the spinal cord	55618
@NP	proprioceptive inputs	55618
@NP	reflex arcs within the spinal cord	55643
@NP	reflex arcs	55643
@NP	the spinal cord	55662
@NP	this test	55690
@NP	reorganization	55719
@NP	the isolated distal spinal cord than functional regeneration of longtracts	55737
@NP	the isolated distal spinal cord	55737
@NP	functional regeneration of longtracts	55774
@NP	functional regeneration	55774
@NP	longtracts	55801
@NP	this respect	55816
@NP	our findings using an inclined gridwalk	55829
@NP	our findings	55829
@NP	an inclined gridwalk	55848
@NP	those of Ramon-Cueto -LRB- Ramon-Cueto , 2000 -RRB-	55881
@NP	those	55881
@NP	Ramon-Cueto -LRB- Ramon-Cueto , 2000 -RRB-	55890
@NP	Ramon-Cueto	55890
@NP	Ramon-Cueto	55903
@NP	2000	55916
@NP	The gridwalk test	55923
@NP	the analysis	55966
@NP	stepping errors	55993
@NP	e.g. footfalls -LRB- unpublished data -RRB- -LRB- DeLucia et al. , 2003 -RRB-	56010
@NP	e.g.	56010
@NP	footfalls -LRB- unpublished data -RRB- -LRB- DeLucia et al. , 2003 -RRB-	56015
@NP	footfalls -LRB- unpublished data -RRB-	56015
@NP	footfalls	56015
@NP	unpublished data	56026
@NP	DeLucia	56045
@NP	et al. , 2003	56053
@NP	et al.	56053
@NP	2003	56061
@NP	the CST	56080
@NP	some effect of the transplantation	56095
@NP	some effect	56095
@NP	the transplantation	56110
@NP	regeneration	56131
@NP	Behavioral recovery	56159
@NP	the absence of CST axonal regeneration	56191
@NP	the absence	56191
@NP	CST axonal regeneration	56206
@NP	CST fibers	56268
@NP	recovery of weightsupported hind-limb locomotion	56301
@NP	recovery	56301
@NP	weightsupported hind-limb locomotion	56313
@NP	The transplanted cells	56351
@NP	the collateralization of the CSTand	56385
@NP	the collateralization	56385
@NP	the CSTand	56410
@NP	the appearance of the terminals	56421
@NP	the appearance	56421
@NP	the terminals	56439
@NP	The current literature	56454
@NP	conflicting data	56486
@NP	the capacity of transplanted OEG	56513
@NP	the capacity	56513
@NP	transplanted OEG	56529
@NP	CST axonal regeneration	56557
@NP	Raisman	56582
@NP	2000	56591
@NP	Ramon-Cueto	56597
@NP	et al. , 2000 ; Nash et al. , 2002 ; Deumens et al. , 2006 ; Ruitenberg et al.	56609
@NP	et al. , 2000	56609
@NP	et al.	56609
@NP	2000	56617
@NP	Nash et al. , 2002	56623
@NP	Nash	56623
@NP	et al. , 2002	56628
@NP	et al.	56628
@NP	2002	56636
@NP	Deumens et al. , 2006	56642
@NP	Deumens	56642
@NP	et al. , 2006	56650
@NP	et al.	56650
@NP	2006	56658
@NP	Ruitenberg et al.	56664
@NP	Ruitenberg	56664
@NP	et al.	56675
@NP	2005	56683
@NP	The observations	56690
@NP	the current study concur	56710
@NP	those studies	56740
@NP	CST regeneration	56763
@NP	transplantation	56812
@NP	thoracic lesions	56841
@NP	Nieto-Sampedro	56859
@NP	2003 ; Takami et al. , 2002 ; Barakat et al. , 2005 ; Fouad et al.	56875
@NP	2003	56875
@NP	Takami et al. , 2002 ; Barakat et al. , 2005 ; Fouad et al.	56881
@NP	Takami	56881
@NP	et al. , 2002 ; Barakat et al. , 2005 ; Fouad et al.	56888
@NP	et al. , 2002	56888
@NP	et al.	56888
@NP	2002	56896
@NP	Barakat et al. , 2005	56902
@NP	Barakat	56902
@NP	et al. , 2005	56910
@NP	et al.	56910
@NP	2005	56918
@NP	Fouad et al.	56924
@NP	Fouad	56924
@NP	et al.	56930
@NP	2005	56938
@NP	those	56969
@NP	collateral formation	56994
@NP	OEG transplantation	57043
@NP	the spinal cord	57066
@NP	Chuah	57083
@NP	et al. , 2004	57089
@NP	et al.	57089
@NP	2004	57097
@NP	facial nerve	57107
@NP	Guntinas-Lichius	57121
@NP	et al. , 2001	57138
@NP	et al.	57138
@NP	2001	57146
@NP	The reduced cavity volumes following OEG transplantation	57153
@NP	The reduced cavity volumes	57153
@NP	OEG transplantation	57190
@NP	a neurotrophic effect	57230
@NP	the role of trophic molecules	57263
@NP	the role	57263
@NP	trophic molecules	57275
@NP	exogenous NT-3	57294
@NP	intact and lesioned CST	57356
@NP	Jeffery and Fitzgerald , 2001 ; Schnell et al. , 1994	57381
@NP	Jeffery and Fitzgerald	57381
@NP	2001 ; Schnell et al.	57405
@NP	2001	57405
@NP	Schnell et al.	57411
@NP	Schnell	57411
@NP	et al.	57419
@NP	1994	57427
@NP	OEGS	57443
@NP	levels of NT-3 close	57473
@NP	levels	57473
@NP	NT-3 close	57483
@NP	those used in these exogenous applications	57497
@NP	those	57497
@NP	these exogenous applications	57511
@NP	Few studies	58100
@NP	5-HT fiber regeneration	58128
@NP	behavioral recovery -LRB- Fouad et al. , 2005 -RRB- and even fewer	58157
@NP	behavioral recovery -LRB- Fouad et al. , 2005 -RRB-	58157
@NP	behavioral recovery	58157
@NP	Fouad	58178
@NP	et al. , 2005	58184
@NP	et al.	58184
@NP	2005	58192
@NP	even fewer	58202
@NP	a step of retransection	58224
@NP	a step	58224
@NP	retransection	58234
@NP	these regenerated fibers	58263
@NP	the observed recovery -LRB- Lu et al. , 2001 -RRB-	58306
@NP	the observed recovery	58306
@NP	Lu	58329
@NP	et al. , 2001	58332
@NP	et al.	58332
@NP	2001	58340
@NP	this study	58350
@NP	the number	58362
@NP	regenerated fiberswas	58376
@NP	the extent of open field	58418
@NP	the extent	58418
@NP	open field	58432
@NP	locomotor recovery -LRB- Fouad et al. , 2005 -RRB-	58443
@NP	locomotor recovery	58443
@NP	Fouad	58463
@NP	et al. , 2005	58469
@NP	et al.	58469
@NP	2005	58477
@NP	the recovery	58492
@NP	such fibers	58523
@NP	all others crossing the transection	58540
@NP	all others	58540
@NP	the transection	58560
@NP	the transplant	58608
@NP	the neurocircuitry	58632
@NP	the isolated spinal cord segment	58658
@NP	the isolated spinal cord	58658
@NP	segment	58683
@NP	7 -RRB- POEG transfection	58692
@NP	their unequivocal identification	58721
@NP	GFP	58755
@NP	at least 42 days following transplantation of transfected OEGs in nude rats	58777
@NP	at least 42 days	58777
@NP	transplantation of transfected OEGs in nude rats	58804
@NP	transplantation	58804
@NP	OEGs in nude rats	58835
@NP	OEGs	58835
@NP	nude rats	58843
@NP	the labeling pattern	58857
@NP	Hoechst	58904
@NP	Previous reports	58913
@NP	OEG	58950
@NP	the spinal cord stump	58967
@NP	the transection site	58994
@NP	transplantation -LRB- Ramon-Cueto et al. , 2000 -RRB-	59025
@NP	transplantation	59025
@NP	Ramon-Cueto	59042
@NP	et al. , 2000	59054
@NP	et al.	59054
@NP	2000	59062
@NP	Most authors who have transplanted OEG directly into or adjacent to lesion sites	59069
@NP	Most authors	59069
@NP	OEG	59104
@NP	lesion sites	59137
@NP	minimal migration	59161
@NP	Plant	59180
@NP	et al. , 2003 ; Deng et al. , 2006 ; Lu et al. , 2006 ; Richter et al. , 2005	59186
@NP	et al. , 2003	59186
@NP	et al.	59186
@NP	2003	59194
@NP	Deng et al. , 2006	59200
@NP	Deng	59200
@NP	et al. , 2006	59205
@NP	et al.	59205
@NP	2006	59213
@NP	Lu et al. , 2006	59219
@NP	Lu	59219
@NP	et al. , 2006	59222
@NP	et al.	59222
@NP	2006	59230
@NP	Richter et al. , 2005	59236
@NP	Richter	59236
@NP	et al. , 2005	59244
@NP	et al.	59244
@NP	2005	59252
@NP	the current study	59262
@NP	Hoechst-positive cells	59280
@NP	the transection site	59317
@NP	the central canal	59342
@NP	the pia mater	59364
@NP	the spinal cord parenchyma up to 5 mm	59390
@NP	the spinal cord parenchyma	59390
@NP	5 mm	59423
@NP	the transection site	59433
@NP	the distribution of GFP-transfected primate OEG	59464
@NP	the distribution	59464
@NP	GFP-transfected primate OEG	59484
@NP	Hoechstpositive cells within the central canal	59522
@NP	Hoechstpositive cells	59522
@NP	the central canal	59551
@NP	GFP	59574
@NP	the most intense migration of GFP-positive cells	59592
@NP	the most intense migration	59592
@NP	GFP-positive cells	59622
@NP	scar tissue and nerve roots	59661
@NP	some cells	59698
@NP	the spinal cord	59723
@NP	Some GFP reaction product	59740
@NP	probable macrophages	59788
@NP	Hoechst labeling	59810
@NP	an unreliable marker of transplanted OEGs in this study	59831
@NP	an unreliable marker	59831
@NP	transplanted OEGs in this study	59855
@NP	transplanted OEGs	59855
@NP	this study	59876
@NP	Nerve roots	59888
@NP	a superior compartment for survival of OEG	59913
@NP	a superior compartment	59913
@NP	survival of OEG	59940
@NP	survival	59940
@NP	OEG	59952
@NP	This observation	59957
@NP	us	59980
@NP	the cells	60001
@NP	an effect	60021
@NP	dorsal root afferent fibers	60034
@NP	spinal reflex arcs	60081
@NP	Li	60101
@NP	et al. , 2004	60104
@NP	et al.	60104
@NP	2004	60112
@NP	Navarro et al. , 1999	60118
@NP	Navarro	60118
@NP	et al. , 1999	60126
@NP	et al.	60126
@NP	1999	60134
@NP	Ramon-Cueto and Nieto-Sampedro , 1994	60140
@NP	Ramon-Cueto and Nieto-Sampedro	60140
@NP	1994	60172
@NP	Riddell et al. , 2004	60178
@NP	Riddell	60178
@NP	et al. , 2004	60186
@NP	et al.	60186
@NP	2004	60194
@NP	Such an effect	60201
@NP	both rostral and caudal	60228
@NP	the transection site	60255
@NP	locomotor activity	60287
@NP	Novel cellular interactions	60310
@NP	the EM level	60355
@NP	Direct cellular interactions	60369
@NP	a critical factor	60417
@NP	OEGs ability	60438
@NP	regeneration -LRB- Li et al. , 2005a , b ; Lipson et al. , 2003 -RRB-	60462
@NP	regeneration	60462
@NP	Li	60476
@NP	et al. , 2005a , b ; Lipson et al. , 2003	60479
@NP	et al.	60479
@NP	2005a , b ; Lipson et al.	60487
@NP	2005a , b	60487
@NP	2005a	60487
@NP	b	60493
@NP	Lipson et al.	60496
@NP	Lipson	60496
@NP	et al.	60503
@NP	2003	60511
@NP	OEG	60518
@NP	both support axonal growth	60541
@NP	formmyelin	60584
@NP	Devon and Doucette ,1992 ; Franklin et al. , 1996 ; Barnett et al.	60596
@NP	Devon and Doucette ,1992	60596
@NP	Devon	60596
@NP	Doucette ,1992	60606
@NP	Franklin et al. , 1996	60621
@NP	Franklin	60621
@NP	et al. , 1996	60630
@NP	et al.	60630
@NP	1996	60638
@NP	Barnett et al.	60644
@NP	Barnett	60644
@NP	et al.	60652
@NP	2000 ; Kato et al.	60660
@NP	2000	60660
@NP	Kato et al.	60666
@NP	Kato	60666
@NP	et al.	60671
@NP	2000 ; Franklin , 2003	60679
@NP	2000	60679
@NP	Franklin , 2003	60685
@NP	Franklin	60685
@NP	2003	60695
@NP	Cells with unusual dark cytoplasm	60702
@NP	Cells	60702
@NP	unusual dark cytoplasm	60713
@NP	two patterns	60753
@NP	One , simultaneously	60767
@NP	One	60767
@NP	axons	60799
@NP	cytoplasmic contacts with astrocytes in the absence of perineurial cells	60816
@NP	cytoplasmic contacts	60816
@NP	astrocytes in the absence of perineurial cells	60842
@NP	astrocytes	60842
@NP	the absence of perineurial cells	60856
@NP	the absence	60856
@NP	perineurial cells	60871
@NP	Two	60890
@NP	perineurial encircled fascicles surrounding unmyelinated axons	60902
@NP	perineurial encircled fascicles	60902
@NP	unmyelinated axons	60946
@NP	Contacts with astrocyte processes Some axonal ensheathing cells	60966
@NP	Contacts	60966
@NP	astrocyte processes Some axonal ensheathing cells	60980
@NP	astrocyte processes	60980
@NP	Some axonal ensheathing cells	61000
@NP	direct contact with astrocyte processes	61034
@NP	direct contact	61034
@NP	astrocyte processes	61054
@NP	the injury region	61077
@NP	direct astrocyte contacts	61109
@NP	basal lamina	61155
@NP	transplanted OEG	61194
@NP	SC	61269
@NP	the injured spinal cord -LRB- unpublished data -RRB-	61294
@NP	the injured spinal cord	61294
@NP	unpublished data	61319
@NP	This observation	61338
@NP	the authors	61359
@NP	such astrocyte contacts	61391
@NP	OEG ensheath	61430
@NP	they	61454
@NP	OEG form	61482
@NP	they	61498
@NP	a phenotype	61516
@NP	SC	61539
@NP	a surrounding basal lamina	61548
@NP	perineuria precluding direct contact with astrocytes	61579
@NP	perineuria	61579
@NP	direct contact	61601
@NP	astrocytes	61621
@NP	The cells thatwere ensheathing	61633
@NP	The cells	61633
@NP	thatwere ensheathing	61643
@NP	dense cytoplasm	61668
@NP	an attribute of the xenografted primate cells	61697
@NP	an attribute	61697
@NP	the xenografted primate cells	61713
@NP	similar cellswere	61749
@NP	comparable regions of control-injected spinal cords	61779
@NP	comparable regions	61779
@NP	control-injected spinal cords	61801
@NP	such cells	61841
@NP	extensive previous studies	61860
@NP	transplanted	61892
@NP	human Schwann cell transplantation	61905
@NP	nude rats -LRB- Guest et al. , 1997a , b -RRB-	61943
@NP	nude rats	61943
@NP	Guest	61954
@NP	et al. , 1997a , b	61960
@NP	et al.	61960
@NP	1997a	61968
@NP	b	61974
@NP	That none	61978
@NP	the cells	61991
@NP	dense cytoplasm found within astrocytic parenchyma weremyelinating	62006
@NP	dense cytoplasm	62006
@NP	astrocytic parenchyma weremyelinating	62035
@NP	their	62088
@NP	in-migrating endogenous Schwann cells	62100
@NP	The presence of membrane specializations	62139
@NP	The presence	62139
@NP	membrane specializations	62155
@NP	they	62191
@NP	apoptotic dying cells	62215
@NP	They	62238
@NP	transplanted fibroblasts -LRB- FB -RRB-	62262
@NP	transplanted fibroblasts	62262
@NP	FB	62288
@NP	FB	62300
@NP	punctate adhesions	62325
@NP	astrocytes	62349
@NP	FB	62368
@NP	ensheath axons	62380
@NP	both FB and SC	62409
@NP	astrocytes	62461
@NP	considerable basal lamina and collagen	62475
@NP	considerable basal lamina	62475
@NP	collagen	62505
@NP	these cells	62521
@NP	OEG interacting with host astrocytes	62560
@NP	OEG	62560
@NP	host astrocytes	62581
@NP	Perineurial cells	62598
@NP	The majority of axons in the transection site	62616
@NP	The majority	62616
@NP	axons in the transection site	62632
@NP	axons	62632
@NP	the transection site	62641
@NP	fascicles	62682
@NP	perineurial-like cells	62706
@NP	Such cells	62730
@NP	the function	62769
@NP	ensheathing cell grafts	62785
@NP	Field	62810
@NP	et al. , 2003	62816
@NP	et al.	62816
@NP	2003	62824
@NP	Lakatos et al. , 2003a , b	62830
@NP	Lakatos	62830
@NP	et al. , 2003a , b	62838
@NP	et al.	62838
@NP	2003a	62846
@NP	b	62852
@NP	Li et al. , 1998	62855
@NP	Li	62855
@NP	et al. , 1998	62858
@NP	et al.	62858
@NP	1998	62866
@NP	Barnett and Chang , 2004	62872
@NP	Barnett and Chang	62872
@NP	2004	62891
@NP	a type of ensheathing cell	62911
@NP	a type	62911
@NP	ensheathing cell	62921
@NP	The perineurial cells	62939
@NP	dark cytoplasm	62968
@NP	non-myelinating cells	62997
@NP	dark cytoplasm that loosely ensheathed several axons	63024
@NP	dark cytoplasm	63024
@NP	several axons	63063
@NP	The deposition of basal lamina in the perineuriawas similar to what	63078
@NP	The deposition	63078
@NP	basal lamina in the perineuriawas similar to what	63096
@NP	basal lamina	63096
@NP	the perineuriawas similar to what	63112
@NP	the perineuriawas	63112
@NP	what	63141
@NP	the lamina propria and fila olfactoria	63163
@NP	the Macaque olfactory system -LRB- Herrera et al. , 2005 -RRB-	63205
@NP	the Macaque olfactory system	63205
@NP	Herrera	63235
@NP	et al. , 2005	63243
@NP	et al.	63243
@NP	2005	63251
@NP	Perineuria	63258
@NP	axonal fascicles	63275
@NP	the injury area	63314
@NP	control animals	63335
@NP	they	63355
@NP	cells	63367
@NP	dark cytoplasm	63378
@NP	it	63405
@NP	transplanted cells	63421
@NP	axons	63451
@NP	perineuria	63485
@NP	distinct patterns	63499
@NP	transplanted cells	63527
@NP	It	63565
@NP	the possibility	63595
@NP	OEG transplantation	63616
@NP	in-migration of host SC	63644
@NP	in-migration	63644
@NP	host SC	63660
@NP	some other investigators -LRB- Boyd et al. , 2004 ; Ramer et al. , 2004 -RRB-	63681
@NP	some other investigators	63681
@NP	Boyd	63707
@NP	et al. , 2004 ; Ramer et al. , 2004	63712
@NP	et al.	63712
@NP	2004 ; Ramer et al.	63720
@NP	2004	63720
@NP	Ramer et al.	63726
@NP	Ramer	63726
@NP	et al.	63732
@NP	2004	63740
@NP	these interesting fascicles	63755
@NP	a cooperative interaction	63793
@NP	transplanted POEG	63828
@NP	axons	63857
@NP	in-migrating endogenous Schwann cells	63867
@NP	myelination	63915
@NP	the same fascicle	63934
@NP	This	63953
@NP	another capability	63974
@NP	the plastic repertoire of ensheathing glia	63996
@NP	the plastic repertoire	63996
@NP	ensheathing glia	64022
@VP	is independent	102
@VP	Guest a , b , , L.	224
@VP	to Cure Paralysis , University of Miami , Miami , FL	400
@VP	Cure Paralysis , University of Miami , Miami , FL	403
@VP	may improve the outcome from spinal cord injury	524
@VP	improve the outcome from spinal cord injury	528
@VP	are desirable	612
@VP	using in vitro expanded OEG	662
@VP	in vitro expanded OEG	668
@VP	should be tested	690
@VP	be tested	697
@VP	tested	700
@VP	study expanded primate OEG -LRB- POEG -RRB- xenografts in immunotolerant rodents	802
@VP	expanded primate OEG -LRB- POEG -RRB- xenografts in immunotolerant rodents	808
@VP	to generate purified POEG	904
@VP	generate purified POEG	907
@VP	purified POEG	916
@VP	underwent T9/10 spinal cord transection	1137
@VP	received POEG	1196
@VP	were injected with cell medium	1223
@VP	injected with cell medium	1228
@VP	received lentivirally-GFP-transfected POEG	1262
@VP	was conducted at 6 weeks , 8 weeks , 14 weeks and 23 -- 24 weeks	1330
@VP	conducted at 6 weeks , 8 weeks , 14 weeks and 23 -- 24 weeks	1334
@VP	were studied with 5-HT immunostaining , 16 with BDA anterograde CST labeling	1412
@VP	studied with 5-HT immunostaining , 16 with BDA anterograde CST labeling	1417
@VP	were used for transmission electron microscopy	1497
@VP	used for transmission electron microscopy	1502
@VP	sprouting	1586
@VP	was observed	1727
@VP	observed	1731
@VP	Grafted animals	1741
@VP	had less	1757
@VP	peaked at three months and then declined	1838
@VP	peaked at three months	1838
@VP	declined	1870
@VP	had shown behavioral recovery	1916
@VP	shown behavioral recovery	1920
@VP	did not account for the locomotor improvement	2069
@VP	account for the locomotor improvement	2077
@VP	forming the glia limitans , distinct from those formed by Schwann cells	2213
@VP	formed by Schwann cells	2260
@VP	was detected in cells within the lesion site and within nerve roots	2311
@VP	detected in cells within the lesion site and within nerve roots	2315
@VP	did not match the pattern of Hoechst nuclear labeling	2383
@VP	match the pattern of Hoechst nuclear labeling	2391
@VP	could be detected	2492
@VP	be detected	2498
@VP	detected	2501
@VP	appear to be independent	2577
@VP	to be independent	2584
@VP	be independent	2587
@VP	have utilized rodent cells	3967
@VP	utilized rodent cells	3972
@VP	testing the properties of primate and human OEG	4016
@VP	can not be overemphasized	4097
@VP	be overemphasized	4104
@VP	overemphasized	4107
@VP	necessitating considerable in vitro expansion	4265
@VP	expanded primate OEG	4335
@VP	have not been reported	4356
@VP	been reported	4365
@VP	reported	4370
@VP	are cultured and transplanted when using nasal tissue as the OEG source	4910
@VP	cultured and transplanted when using nasal tissue as the OEG source	4914
@VP	using nasal tissue as the OEG source	4945
@VP	to derive OEG to prevent inadvertent culture of SC	5195
@VP	derive OEG to prevent inadvertent culture of SC	5198
@VP	to prevent inadvertent culture of SC	5209
@VP	prevent inadvertent culture of SC	5212
@VP	associated fibers	5315
@VP	are not present in the OB -LRB- Herrera et al. , 2005 -RRB-	5333
@VP	to replicate and extend the study by Ramon-Cueto et al.	5614
@VP	replicate and extend the study by Ramon-Cueto et al.	5617
@VP	replicate	5617
@VP	extend the study by Ramon-Cueto	5631
@VP	to test long term duration of functional recovery ,	5778
@VP	test long term duration of functional recovery ,	5781
@VP	re-transecting a subset of transplanted spinal cords	5837
@VP	determine whether such recovery	5894
@VP	is the result of long tract regeneration	5926
@VP	was assessed in comparison to control media-injected spinal transected nude rats	6090
@VP	assessed in comparison to control media-injected spinal transected nude rats	6094
@VP	to control media-injected spinal transected nude rats	6117
@VP	control media-injected spinal transected nude rats	6120
@VP	opposed to a cellular control	6197
@VP	was selected because OEGs likely	6227
@VP	selected because OEGs likely	6231
@VP	associated with the transection and injection procedure itself	6455
@VP	to test the validity of the Hoechst label	6660
@VP	test the validity of the Hoechst label	6663
@VP	thatwere both Hoechst-labeled and lentivirallytransfected to express GFP	6760
@VP	to express GFP	6818
@VP	express GFP	6821
@VP	was observed	7130
@VP	observed	7134
@VP	was associated with declining behavioral function	7221
@VP	associated with declining behavioral function	7225
@VP	was assessed	7957
@VP	assessed	7961
@VP	was compared in the transplanted andmedia-only injected animals	8006
@VP	compared in the transplanted andmedia-only injected animals	8010
@VP	containing reactive astrocytes and axons	8156
@VP	were analyzed using transmission electron microscopy -LRB- TEM -RRB-	8197
@VP	analyzed using transmission electron microscopy -LRB- TEM -RRB-	8202
@VP	using transmission electron microscopy -LRB- TEM -RRB-	8211
@VP	was approved by the University of Miami Institutional Biosafety Committee	8457
@VP	approved by the University of Miami Institutional Biosafety Committee	8461
@VP	sharing program	8695
@VP	ranged in age from1 .5 to 10 years -LRB- mean 4.8 + / − 3 years SD -RRB-	8739
@VP	mean 4.8 + / − 3 years SD	8774
@VP	were Macaca mulata and five were Macaca fascicularis	8814
@VP	were Macaca fascicularis	8842
@VP	did not exceed 3 h	8983
@VP	exceed 3 h	8991
@VP	were recovered from all specimens	9019
@VP	recovered from all specimens	9024
@VP	kept on ice until dissection on the same day	9273
@VP	Using a dissecting microscope the ventral portion of both olfactory bulbs	9319
@VP	was dissected free of attached blood vessels and arachnoid	9393
@VP	dissected free of attached blood vessels and arachnoid	9397
@VP	attached blood vessels and arachnoid	9415
@VP	dissected away fromthewhitematter of the remaining olfactory bulb and tract	9492
@VP	andwashed three times in L-15 to remove the enzymes	9947
@VP	to remove the enzymes	9977
@VP	remove the enzymes	9980
@VP	ammoniated rat-tail collagen	10143
@VP	containing 10 % HIFCS	10301
@VP	was changed every three days	10334
@VP	changed every three days	10338
@VP	was expanded for seven days prior to immunopanning	10384
@VP	expanded for seven days prior to immunopanning	10388
@VP	contained approximately 1.2 million cells	10473
@VP	was rinsed three times with 0.1 M Tris -LRB- pH 9.5 -RRB-	10814
@VP	was applied to the dish at room temperature for 1 h.	10991
@VP	applied to the dish at room temperature for 1 h.	10995
@VP	Cultured	11044
@VP	centrifuged	11108
@VP	washed three times in DMEM	11121
@VP	then seeded onto the immunopanning plate	11153
@VP	to adhere for 30 min at 4 °C and then non-adherent cellswerewashed off the dish	11267
@VP	adhere for 30 min at 4 °C and then non-adherent cellswerewashed off the dish	11270
@VP	cellswerewashed off the dish	11318
@VP	were then passaged again , expanded to confluence , and used for transplantation	11473
@VP	passaged again , expanded to confluence , and used for transplantation	11483
@VP	passaged again	11483
@VP	expanded to confluence	11499
@VP	used for transplantation	11527
@VP	had been had been in culture for a total of approximately 27 -- 33 days	11579
@VP	been had been in culture for a total of approximately 27 -- 33 days	11583
@VP	had been in culture for a total of approximately 27 -- 33 days	11588
@VP	been in culture for a total of approximately 27 -- 33 days	11592
@VP	derived from the two olfactory bulbs of one primate	11659
@VP	were used for 3 -- 6 rodent transplantations	11711
@VP	used for 3 -- 6 rodent transplantations	11716
@VP	centrifuged and rinsed three times with L-15	12115
@VP	using trypan blue exclusion to assess the cell viability	12196
@VP	to assess the cell viability	12224
@VP	assess the cell viability	12227
@VP	prepared as above	12283
@VP	were exposed to lentivirus 6/VS-GFP -LRB- courtesy of Dr.	12301
@VP	exposed to lentivirus 6/VS-GFP -LRB- courtesy of Dr.	12306
@VP	driven by a cytomegalovirus promoter	12445
@VP	enhanced by the Woodchuck	12486
@VP	were washed three times with DMEM	12641
@VP	washed three times with DMEM	12646
@VP	was replaced	12701
@VP	replaced	12705
@VP	weighing 140-155 g	12803
@VP	To prevent urinary infection	12952
@VP	prevent urinary infection	12955
@VP	occurred	13180
@VP	were added to drinking water to suppress chronic bacterial infection	13250
@VP	added to drinking water to suppress chronic bacterial infection	13255
@VP	to suppress chronic bacterial infection	13279
@VP	suppress chronic bacterial infection	13282
@VP	developed during the survival period	13399
@VP	was maintained at 37	13464
@VP	maintained at 37	13468
@VP	was performed under sterile conditions	13569
@VP	performed under sterile conditions	13573
@VP	was performed	13646
@VP	performed	13650
@VP	transected at the T9/T10 level	13680
@VP	taking particular care to cut the lateral spinal cord	13751
@VP	to cut the lateral spinal cord	13774
@VP	cut the lateral spinal cord	13777
@VP	remained intact across the transection	14024
@VP	received culture medium -LRB- L-15 -RRB- injections	14135
@VP	was perforated with a beveled 33 gauge needle	14233
@VP	attached to a 5 μl syringe held in a Kopf stereotaxic micromanipulator	14444
@VP	held in a Kopf stereotaxic micromanipulator	14471
@VP	injected into the rostral and caudal stumps in the midline	14531
@VP	described by Ramon-Cueto	14593
@VP	received a total of 400,000 cells	14666
@VP	were injected at four depths -LRB- 200,000 cells/2 μl/stump -RRB-	14733
@VP	injected at four depths -LRB- 200,000 cells/2 μl/stump -RRB-	14738
@VP	were made by pressure at 0.5 μl per minute	14801
@VP	made by pressure at 0.5 μl per minute	14806
@VP	was complete	14865
@VP	to reduce cell extrusion from the injection site	14933
@VP	reduce cell extrusion from the injection site	14936
@VP	was not cut	15006
@VP	cut	15014
@VP	exceeded seven at eight weeks post-transplantation	15228
@VP	underwent retransection at T9/10	15279
@VP	were assessed for a subsequent four weeks	15334
@VP	assessed for a subsequent four weeks	15339
@VP	underwent anesthesia with rat cocktail -LRB- 0.5 ml/kg -RRB-	15601
@VP	biotinylated dextran amine -LRB- BDA ,10,000	15719
@VP	injected into the motor cortex bilaterally -LRB- Guest et al. , 1997a , b -RRB-	15809
@VP	were performed per side at a depth of 0.7 mmfrom the cortical surface	15903
@VP	performed per side at a depth of 0.7 mmfrom the cortical surface	15908
@VP	were pre-trained in the open field as described by Basso et al.	16135
@VP	described by Basso et al.	16173
@VP	independently assigned a BBB score and then the mean score	16368
@VP	was recorded	16427
@VP	recorded	16431
@VP	were video-taped for further analysis	16477
@VP	coding employed	16534
@VP	employed	16541
@VP	know if they were evaluating an OEGtransplanted , or control media-injected rat	16571
@VP	were evaluating an OEGtransplanted , or control media-injected rat	16584
@VP	evaluating an OEGtransplanted , or control media-injected rat	16589
@VP	OEGtransplanted	16603
@VP	followed by a Bonferroni	16736
@VP	to correct for multiple comparisons	16771
@VP	correct for multiple comparisons	16774
@VP	selected for retransectionwere assessed using a paired t-test	16834
@VP	assessed using a paired t-test	16865
@VP	using a paired t-test	16874
@VP	could be varied as	16982
@VP	be varied as	16988
@VP	varied as	16991
@VP	described by Ramon-Cueto et al.	17001
@VP	was constructed	17060
@VP	constructed	17064
@VP	assessed for their ability to ascend this ramp once weekly throughout the study	17121
@VP	to ascend this ramp once weekly throughout the study	17148
@VP	ascend this ramp once weekly throughout the study	17151
@VP	was initially set at 45 degrees	17211
@VP	set at 45 degrees	17225
@VP	could ascend at least 30 cm within 1 min	17308
@VP	ascend at least 30 cm within 1 min	17314
@VP	was determined by a tester blinded to the rat 's control or transplant status	17349
@VP	determined by a tester blinded to the rat 's control or transplant status	17353
@VP	blinded to the rat 's control or transplant status	17376
@VP	injected rats as described above	17523
@VP	described above	17540
@VP	were performed by one of the authors -LRB- M.O. -RRB- , a qualified veterinarian	17732
@VP	performed by one of the authors -LRB- M.O. -RRB- , a qualified veterinarian	17737
@VP	were assessed for evidence of gross injury	17821
@VP	assessed for evidence of gross injury	17826
@VP	was removed	17882
@VP	removed	17886
@VP	opened	17924
@VP	bisected in the plane of their renal calyx	17947
@VP	had urine cultures and renal stoneswere analyzed fromsix animals	18003
@VP	analyzed fromsix animals	18043
@VP	using Spearman 's correlation test in GraphPad Instat , version 3.05	18256
@VP	assessing for the presence of calculi in the bladder -LRB- 1 point -RRB-	18376
@VP	scored from0 -- 3 points	18530
@VP	Using this scale animals with no calculi and normal appearing kidneys	18553
@VP	ranging from 23 to 24 weeks	18774
@VP	containing heparin -LRB- 5000 U.I / L -RRB- followed by 4 %	18953
@VP	followed by 4 %	18985
@VP	buffered paraformaldehyde	19000
@VP	studied spinal cord	19167
@VP	removed and embedded in gelatin -LRB- Oudega et al. ,1994 -RRB-	19295
@VP	then placed into KPBS -LRB- 0.1 M -RRB- containing 20 % sucrose	19352
@VP	containing 20 % sucrose	19382
@VP	To assess labeled CST fibers	19424
@VP	assess labeled CST fibers	19427
@VP	using a sliding freezingmicrotome	19584
@VP	to be viewed in the dorsal -- ventral or horizontal plane	19651
@VP	be viewed in the dorsal -- ventral or horizontal plane	19654
@VP	viewed in the dorsal -- ventral or horizontal plane	19657
@VP	cut from the left to the right of the spinal cord on a rotatory cryostat	19827
@VP	placed sequentially onto gelatin-coated slides	19904
@VP	was not known to the assessor	20032
@VP	known to the assessor	20040
@VP	equipped with Neurolucida software	20264
@VP	compared	20428
@VP	blocked by pre-incubation in 2 % bovine serum albumin -LRB- Sigma Chemical Co.	20651
@VP	goat serum in KPBS -LRB- 0.1 M -RRB- to minimize non-specific binding	20747
@VP	to minimize non-specific binding	20773
@VP	minimize non-specific binding	20776
@VP	containing 2 % goat serum and 0.1 % Triton-X overnight at 4 °C	20903
@VP	washed three times with KPBS	20974
@VP	followed by three washes	21127
@VP	were coated with Citifluor -LRB- UKC Chemical laboratory -RRB-	21191
@VP	coated with Citifluor -LRB- UKC Chemical laboratory -RRB-	21196
@VP	coverslipped	21249
@VP	connected to a workstation running Neurolucida software	21354
@VP	running Neurolucida software	21381
@VP	were acquired using Neurolucida and then analyzed in Adobe Photoshop	21628
@VP	acquired using Neurolucida and then analyzed in Adobe Photoshop	21633
@VP	acquired using Neurolucida	21633
@VP	using Neurolucida	21642
@VP	then analyzed in Adobe Photoshop	21664
@VP	was linearly correlated with peak BBB scores	21734
@VP	correlated with peak BBB scores	21747
@VP	sprouting	21819
@VP	To identify anterogradely	21909
@VP	identify anterogradely	21912
@VP	transported BDA in CST processes	21935
@VP	were embedded in gelatin and cut as described above	22045
@VP	embedded in gelatin and cut as described above	22050
@VP	described above	22081
@VP	were serially collected into 24 well plates	22161
@VP	collected into 24 well plates	22175
@VP	to quench endogenous peroxide	22276
@VP	quench endogenous peroxide	22279
@VP	exposed to avidin -- biotin peroxidase -LRB- PK-6105 Elite , Vector , Burlingame	22322
@VP	to avidin	22330
@VP	avidin	22333
@VP	buffered saline	22499
@VP	using a Zeiss Axiophot microscope connected to a computer running Neurolucida	22787
@VP	connected to a computer running Neurolucida	22821
@VP	running Neurolucida	22845
@VP	were performed	23083
@VP	performed	23088
@VP	emerged at right angles to a longitudinally-oriented CST process	23288
@VP	To perform this analysis	23354
@VP	perform this analysis	23357
@VP	labeled with BDA in each animal	23440
@VP	were selected	23472
@VP	selected	23477
@VP	could be seen between the longitudinal process	23656
@VP	be seen between the longitudinal process	23662
@VP	seen between the longitudinal process	23665
@VP	emerging from it	23737
@VP	were counted	23754
@VP	counted	23759
@VP	was evaluated as a ratio	24033
@VP	evaluated as a ratio	24037
@VP	differs between animals	24150
@VP	described by -LRB- Hill et al. , 2004 -RRB-	24253
@VP	defined as having at least 20 μm of axon on either side of the distension	24324
@VP	having at least 20 μm of axon on either side of the distension	24335
@VP	were counted	24399
@VP	counted	24404
@VP	were counted in the five terminal mm of BDA anterograde	24574
@VP	counted in the five terminal mm of BDA anterograde	24579
@VP	traced CST of control and OEG-transplanted rats	24630
@VP	reduced loss of parenchyma fromthe spinal cord stumpswe	24752
@VP	injected	24885
@VP	transplanted rats	24915
@VP	examined under autofluorescence	25016
@VP	created in Neurolucida	25073
@VP	was determined	25131
@VP	determined	25135
@VP	was examined for a distance of 600 μmlaterally -LRB- total 1.2 mm -RRB-	25194
@VP	examined for a distance of 600 μmlaterally -LRB- total 1.2 mm -RRB-	25198
@VP	were demarcated using Neurolucida and the area determined	25265
@VP	demarcated using Neurolucida and the area determined	25270
@VP	using Neurolucida and the area determined	25281
@VP	determined	25312
@VP	thus obtained	25349
@VP	to generate average volumes of cavitation	25435
@VP	generate average volumes of cavitation	25438
@VP	were compared using a 2 tailed t-test in Instat 3.05	25484
@VP	compared using a 2 tailed t-test in Instat 3.05	25489
@VP	using a 2 tailed t-test in Instat 3.05	25498
@VP	tailed t-test in Instat 3.05	25508
@VP	transplanted	25602
@VP	were used for transmission electron microscopy -LRB- TEM -RRB-	25626
@VP	used for transmission electron microscopy -LRB- TEM -RRB-	25631
@VP	exposed to 1 % osmium , embedded in Araldite , and stained with toluidine blue	25807
@VP	exposed to 1 % osmium	25807
@VP	embedded in Araldite	25829
@VP	stained with toluidine blue	25855
@VP	coded animal regions of interest from within the scar tissue between the stumps	25893
@VP	were identified in 1 μm plastic sections	26043
@VP	identified in 1 μm plastic sections	26048
@VP	were prepared and examined using a Philips CM10 electron microscope	26109
@VP	prepared and examined using a Philips CM10 electron microscope	26114
@VP	using a Philips CM10 electron microscope	26136
@VP	were assessed for axons at 1650 ×	26191
@VP	assessed for axons at 1650 ×	26196
@VP	were obtained	26263
@VP	obtained	26268
@VP	coordinates	26282
@VP	recorded	26321
@VP	were obtained at 6000 to 14000 ×	26383
@VP	obtained at 6000 to 14000 ×	26388
@VP	may be an astrocyte	26755
@VP	be an astrocyte	26759
@VP	are both found in the primary cultures	26839
@VP	found in the primary cultures	26848
@VP	is shown in axial section	26907
@VP	shown in axial section	26910
@VP	is then dissected from the remaining OB , and enzymatically digested	27049
@VP	dissected from the remaining OB , and enzymatically digested	27057
@VP	dissected from the remaining OB	27057
@VP	digested	27108
@VP	performed at one week on the total cell numbers in the culture	27157
@VP	shown	27248
@VP	exposed to the eGFP lentiviral vector for 48 h	27462
@VP	show a high rate of transfection	27509
@VP	is shown with characteristic excellent healing between the stumps	27575
@VP	shown with characteristic excellent healing between the stumps	27578
@VP	were a frequent finding	27693
@VP	exposed to GFP lentiviral vector for 48 h	27756
@VP	were transplanted into the spinal cord stumps	27798
@VP	transplanted into the spinal cord stumps	27803
@VP	was perfused after 42 days	27864
@VP	perfused after 42 days	27868
@VP	were cut	27922
@VP	cut	27927
@VP	was not extensive	27966
@VP	magnified in the right corner inset	28090
@VP	left	28274
@VP	were GFP negative	28280
@VP	Note the characteristic microcavitation within the spinal cord stumps	28299
@VP	= 0.8 mm	28373
@VP	show superior behavioral recovery	28417
@VP	filled boxes	28527
@VP	is shown in green	28672
@VP	shown in green	28675
@VP	post retransection	28763
@VP	are seen	28782
@VP	seen	28786
@VP	is shown	28904
@VP	shown	28907
@VP	was acquired at 37 frames per second	28920
@VP	acquired at 37 frames per second	28924
@VP	is shown	28980
@VP	shown	28983
@VP	-LRB- See supplemental video POEG17 BBB -RRB-	28990
@VP	See supplemental video POEG17 BBB -RRB-	28991
@VP	is shown ascending the wire mesh ramp at 75 degrees	29062
@VP	shown ascending the wire mesh ramp at 75 degrees	29065
@VP	ascending the wire mesh ramp at 75 degrees	29071
@VP	is shown	29140
@VP	shown	29143
@VP	-LRB- See supplemental video POEG30a ramp -RRB-	29150
@VP	See supplemental video POEG30a ramp -RRB-	29151
@VP	are shown	29346
@VP	shown	29350
@VP	has evidence of distension	29375
@VP	contains soft and firm masses that consisted of calcium carbonate and oxalate	29406
@VP	consisted of calcium carbonate and oxalate	29441
@VP	show blunting of the calyces with cortical and medullary scarring	29503
@VP	blunting of the calyces with cortical and medullary scarring	29508
@VP	is consistent with chronic pyelonephritis and renal calculi formation	29575
@VP	be detected in the bladder and kidney -LRB- 2 -RRB- but renal parenchymal damage	29722
@VP	detected in the bladder and kidney -LRB- 2 -RRB- but renal parenchymal damage	29725
@VP	is	29793
@VP	are also present in both the bladder and kidneys -LRB- 2 -RRB-	29837
@VP	is severe -LRB- 3 -RRB- , total score = 5	29923
@VP	is shown	30167
@VP	shown	30170
@VP	is no die-back of 5-HT fibers	30208
@VP	are visible surrounding the cavities and at the margin of the transection site	30275
@VP	surrounding the cavities and at the margin of the transection site	30287
@VP	is to the left	30363
@VP	Magnified region of central box in A.	30382
@VP	can be visualized to extend into the distal spinal cord stump	30436
@VP	be visualized to extend into the distal spinal cord stump	30440
@VP	visualized to extend into the distal spinal cord stump	30443
@VP	to extend into the distal spinal cord stump	30454
@VP	extend into the distal spinal cord stump	30457
@VP	Magnified region of distal box in A.	30502
@VP	is visualized at the distal end of the section , a distance of 7.1 cm	30547
@VP	visualized at the distal end of the section , a distance of 7.1 cm	30550
@VP	= 2.5 mm	30620
@VP	has been overlaid	30802
@VP	been overlaid	30806
@VP	overlaid	30811
@VP	= 2 mm	30824
@VP	used for A.	30892
@VP	emerging from rostral intact CST fibers	30975
@VP	bar = 100 μm	31016
@VP	= 100 μm	31019
@VP	are seen to ensheath but not to myelinate axons in this fascicle	31166
@VP	seen to ensheath but not to myelinate axons in this fascicle	31170
@VP	is not characteristic of Schwann cells	31249
@VP	is present on the outer membrane surfaces -LRB- black arrow -RRB-	31302
@VP	is surrounded by a typical perineurial cellular process -LRB- white arrow -RRB-	31372
@VP	surrounded by a typical perineurial cellular process -LRB- white arrow -RRB-	31375
@VP	seen immediately adjacent to several astrocyte processes and unmyelinated axons	31565
@VP	identified by the presence of microtubules , dark asterisk	31721
@VP	processes with minimal intervening basal lamina -LRB- white arrow -RRB-	31808
@VP	intervening basal lamina -LRB- white arrow -RRB-	31831
@VP	has zonula-type junctions with astrocyte processes -LRB- small asterisk -RRB-	31917
@VP	are present between the astrocyte processes -LRB- large asterisk -RRB-	32027
@VP	died prior to the end-point	32165
@VP	were lost for purposes of histological analysis	32197
@VP	lost for purposes of histological analysis	32202
@VP	presumably due to chronic renal damage	32246
@VP	explained below	32288
@VP	had a control injection and 4	32395
@VP	had OEG injections	32425
@VP	was 9 %	32479
@VP	was 2.1 which was not statistically significant p = 0.66	32522
@VP	was not statistically significant p = 0.66	32536
@VP	is illustrated in Fig. 1C	32674
@VP	illustrated in Fig. 1C	32677
@VP	was 8000 + / − 3000 cells per mg starting tissue	32769
@VP	observed	32994
@VP	were usually S-100 positive	33281
@VP	were p75 positive	33315
@VP	were not	33344
@VP	were seen	33389
@VP	seen	33394
@VP	indicating that p75 immunopanning selects against these cells	33408
@VP	selects against these cells	33442
@VP	performed at seven days	33494
@VP	resulted in a considerable overall cell loss as illustrated in Fig. 1D	33518
@VP	illustrated in Fig. 1D	33566
@VP	to obtain sufficient cells for transplantation	33696
@VP	obtain sufficient cells for transplantation	33699
@VP	did not exclude trypan blue	34229
@VP	exclude trypan blue	34237
@VP	The transplanted cellular suspensions varied from 83 -- 96 % p75 positive	34308
@VP	varied from 83	34346
@VP	are fibronectin-positive putative fibroblasts -LRB- J.	34475
@VP	suggesting such cells	34551
@VP	could have made up as many as 4 -- 17 % of the cells in the transplant	34573
@VP	have made up as many as 4 -- 17 % of the cells in the transplant	34579
@VP	made up as many as 4 -- 17 % of the cells in the transplant	34584
@VP	existed between primate donor age or sex and the cell yields or final p75 purity	34663
@VP	were not found in the transplanted cellular suspensions	34770
@VP	found in the transplanted cellular suspensions	34779
@VP	purified primate OEG cultures with pLenti6	34893
@VP	using an MOI of 50:1 -LRB- Fig. 2A , B -RRB-	35008
@VP	shown in Fig. 3A	35216
@VP	was apparent by eight weeks post-transplantation	35303
@VP	peaked at 12 weeks and thereafter declined	35383
@VP	peaked at 12 weeks	35383
@VP	declined	35417
@VP	stepping -LRB- Fig. 3B -RRB-	35629
@VP	lacked fore-limb to hind-limb coordination	35657
@VP	had postural instability	35701
@VP	see supplemental video POEG 17 BBB	35768
@VP	corresponds to a BBB score of 11	35810
@VP	showed weight-supported stepping during open field testing	35863
@VP	stepping during open field testing	35887
@VP	had been 7 or greater for two successive weeks	35968
@VP	been 7 or greater for two successive weeks	35972
@VP	underwent retransection at T9/10	36015
@VP	did not	36128
@VP	were 7.4 + / − 0.55 SD	36177
@VP	mean post-retransection scores	36200
@VP	were 6.2 + / − 1.9 SD	36231
@VP	transplanted with lentivirally-transfected cells	36308
@VP	were slightly lower than those transplanted with non-transfected cells	36357
@VP	transplanted with non-transfected cells	36388
@VP	was not significantly different	36448
@VP	-RRB-	36503
@VP	exhibited some degree of stepping locomotor activity on the ramp at 45 degrees	36545
@VP	stepping locomotor activity on the ramp at 45 degrees	36570
@VP	stepping motions and ascent of the grid at 60 degrees -LRB- Fig. 3C -RRB-	36702
@VP	see supplemental video POEG30a ramp and POEG30a BBB	36881
@VP	exhibited clonic posterior limb spasms while on the grid	36952
@VP	exhibited stepping movements and ascent of the grid , Student 's 2-tailed test	37151
@VP	stepping movements and ascent of the grid , Student 's 2-tailed test	37161
@VP	showed some evidence of chronic bladder distension and renal calculi formation	37339
@VP	was identified from lung histology	37543
@VP	identified from lung histology	37547
@VP	tailed	37825
@VP	were correlated with the renal injury score , those of the transplanted animals	37901
@VP	correlated with the renal injury score , those of the transplanted animals	37906
@VP	exists	38169
@VP	did not exist in control animals -LRB- r = 0.36 , p = 0.25 -RRB-	38205
@VP	exist in control animals -LRB- r = 0.36 , p = 0.25 -RRB-	38213
@VP	score recovery	38370
@VP	is therefore less	38438
@VP	found within the bladder and kidneys	38492
@VP	were positive for E. coli andMorganella morgani	38630
@VP	Transplanted	38679
@VP	did not differ in stone composition or identified bacterial organisms	38712
@VP	did not differ in stone composition	38712
@VP	differ in stone composition	38720
@VP	identified bacterial organisms	38751
@VP	were carefully inspected circumferentially to verify completeness of transection	38833
@VP	inspected circumferentially to verify completeness of transection	38848
@VP	to verify completeness of transection	38876
@VP	verify completeness of transection	38879
@VP	filled by scar tissue as seen in Fig. 2C	38992
@VP	seen in Fig. 2C	39017
@VP	were seen in both control-injected	39176
@VP	seen in	39181
@VP	indicated that OEG migrate from the spinal cord stump into the transection site	39296
@VP	migrate from the spinal cord stump into the transection site	39315
@VP	addressed in six animals inwhich the intracellular labels GFP	39394
@VP	inwhich the intracellular labels GFP	39419
@VP	were both employed	39468
@VP	employed	39478
@VP	was very consistent	39762
@VP	differed considerably fromthat of the Hoechst-labeled cells	39823
@VP	were not GFP-positive -LRB- Fig. 2E -RRB-	39940
@VP	were seen to enter spinal nerve roots	39997
@VP	seen to enter spinal nerve roots	40002
@VP	to enter spinal nerve roots	40007
@VP	enter spinal nerve roots	40010
@VP	showed an elongated morphology -LRB- Fig. 2E -RRB-	40039
@VP	elongated morphology -LRB- Fig. 2E -RRB-	40049
@VP	survived better in the nerve root environment -LRB- unpublished data -RRB-	40099
@VP	indicating considerable death or engulfment of the transplanted	40301
@VP	transfected cells	40365
@VP	could be found although GFP-positive debris in macrophages was still present	40443
@VP	be found although GFP-positive debris in macrophages was still present	40449
@VP	found although GFP-positive debris in macrophages was still present	40452
@VP	was still present	40502
@VP	employed in vitro	40572
@VP	is not effective in the fixed tissue of xenografted animals	40590
@VP	is consistent with cell death	40862
@VP	were studied	41019
@VP	studied	41024
@VP	were not counted	41078
@VP	counted	41087
@VP	could be seen into the lesion site and in 6 out	41174
@VP	be seen into the lesion site and in 6 out	41180
@VP	seen into the lesion site and in 6 out	41183
@VP	could be visualized in the distal spinal cord	41266
@VP	be visualized in the distal spinal cord	41272
@VP	visualized in the distal spinal cord	41275
@VP	extend more than 1 mm into the distal spinal cord stump -LRB- Fig. 5A -RRB-	41581
@VP	was 21 + / − 11 fibers	41798
@VP	was no regeneration of 5-HT positive axons in control animals	41824
@VP	was observed in either condition	41920
@VP	observed in either condition	41924
@VP	was evident in any section	41992
@VP	had been completed the number of 5-HT	42084
@VP	been completed the number of 5-HT	42088
@VP	completed the number of 5-HT	42093
@VP	was correlated with the peak BBB scores of the rats	42169
@VP	correlated with the peak BBB scores of the rats	42173
@VP	was observed	42249
@VP	observed	42253
@VP	= 0.68	42273
@VP	were studied	42362
@VP	studied	42367
@VP	Labeling of the CST	42376
@VP	studied for BDA	42455
@VP	neither the transplanted nor	42502
@VP	the transplanted nor	42510
@VP	was evidence of CST fiber regeneration into or beyond the lesion site observed	42547
@VP	observed	42617
@VP	observed	42677
@VP	axotomized end-bulbs in OEGtransplanted rats at the four month time-point	42824
@VP	was not seen -LRB- Fig. 6A -RRB-	42898
@VP	seen -LRB- Fig. 6A -RRB-	42906
@VP	also assessed	43023
@VP	to control animals -LRB- 0.7 + / − 0.5 processes per axon/mm -RRB- in the 2.5	43194
@VP	control animals -LRB- 0.7 + / − 0.5 processes per axon/mm -RRB- in the 2.5	43197
@VP	were few BDA positive processes at all	43361
@VP	assessed	43489
@VP	varied from6 .84 mm3 to 3.3 mm3	43498
@VP	injected animals 5.9 +	43616
@VP	was statistically significant	43665
@VP	containing an interesting mixture of ensheathed and myelinated axons	43908
@VP	were identified -LRB- Fig. 7A -RRB-	43977
@VP	identified -LRB- Fig. 7A -RRB-	43982
@VP	ensheathed axons had unusual dark cytoplasm but themyelinating cells	44019
@VP	had unusual dark cytoplasm but themyelinating cells	44036
@VP	did not have this appearance	44088
@VP	have this appearance	44096
@VP	were ensheathing	44232
@VP	ensheathing	44237
@VP	seen with OEGs as compared to SC	44481
@VP	is incomplete and scant cytoplasm around the axons	44528
@VP	observed in our laboratory -LRB- Herrera et al. , 2005 -RRB-	44909
@VP	resembled those of peripheral nerve	45150
@VP	were also noted in the three transplanted animals	45274
@VP	noted in the three transplanted animals	45284
@VP	forming a punctate adhesion-like structure -LRB- Fig. 7C , small asterisk -RRB-	45703
@VP	is no visible basal lamina	45809
@VP	show similar punctate adhesions -LRB- Fig. 7C , large asterisk -RRB-	45866
@VP	formed in the region of the transection	46022
@VP	is surface basal lamina associated with these astrocytes	46087
@VP	associated with these astrocytes	46111
@VP	studied in high quality photomicrographs under illumination and magnification	46232
@VP	lack the dense filaments of an astrocyte	46478
@VP	also lacks the dense basal lamina seen on adjacent reactive astrocyte processes	46523
@VP	seen on adjacent reactive astrocyte processes	46557
@VP	were seen in animals with medium-only injections	46711
@VP	seen in animals with medium-only injections	46716
@VP	may be successfully expanded	48497
@VP	be successfully expanded	48501
@VP	successfully expanded	48504
@VP	purified from the olfactory bulb	48530
@VP	utilized to enrich olfactory bulb-derived cultures for OEGs	48585
@VP	to enrich olfactory bulb-derived cultures for OEGs	48594
@VP	enrich olfactory bulb-derived cultures for OEGs	48597
@VP	to expand cultures of predominantly p75 positive cells for at least one month	48665
@VP	expand cultures of predominantly p75 positive cells for at least one month	48668
@VP	increased the time needed to obtain sufficient cells for transplantation	48802
@VP	needed to obtain sufficient cells for transplantation	48821
@VP	to obtain sufficient cells for transplantation	48828
@VP	obtain sufficient cells for transplantation	48831
@VP	should be considered in the planning of preclinical studies	48889
@VP	be considered in the planning of preclinical studies	48896
@VP	considered in the planning of preclinical studies	48899
@VP	would be available for the primary culture	49048
@VP	be available for the primary culture	49054
@VP	were utilized	49151
@VP	utilized	49156
@VP	were often as many as 500,000 cells initially	49185
@VP	would comprise the initial cell culture in a primate autotransplantation	49274
@VP	comprise the initial cell culture in a primate autotransplantation	49280
@VP	to derive OEG	49998
@VP	derive OEG	50001
@VP	have been observed -LRB- Herrera et al. , 2005 -RRB-	50190
@VP	been observed -LRB- Herrera et al. , 2005 -RRB-	50195
@VP	observed -LRB- Herrera et al. , 2005 -RRB-	50200
@VP	is no method to separate SC from OEG	50271
@VP	respond to similar mitogens -LRB- Yan et al. , 2001 -RRB-	50318
@VP	using currently available techniques	50447
@VP	measured with the BBB test	50522
@VP	were transplanted with the xenograft cells	50592
@VP	transplanted with the xenograft cells	50597
@VP	may be especially poor	50870
@VP	be especially poor	50874
@VP	clearly showed more locomotor behavioral recovery than control-injected animals	50929
@VP	was observed	51054
@VP	observed	51058
@VP	to control levels as measured with BBB scores	51176
@VP	control levels as measured with BBB scores	51179
@VP	measured with BBB scores	51197
@VP	contributed to this recovery	51347
@VP	to elicit sprouting of labeled sensory axons	51531
@VP	elicit sprouting of labeled sensory axons	51534
@VP	sprouting of labeled sensory axons	51541
@VP	sprouting of CGRP positive sensory fibers -LRB- Richter et al. , 2005 -RRB- .	51621
@VP	may have stimulated sprouting of sensory afferents	51733
@VP	have stimulated sprouting of sensory afferents	51737
@VP	stimulated sprouting of sensory afferents	51742
@VP	sprouting of sensory afferents	51753
@VP	stepping through plasticity of the local stepping circuitry	51810
@VP	stepping circuitry	51851
@VP	measured with the BBB scale	51894
@VP	was not stable over time	51922
@VP	are considered : death of transplanted cells , and chronic systemic illness	51977
@VP	considered : death of transplanted cells , and chronic systemic illness	51981
@VP	could not be found 14 weeks after transplantation but were present at 42 days	52071
@VP	could not be found 14 weeks after transplantation	52071
@VP	be found 14 weeks after transplantation	52081
@VP	found 14 weeks after transplantation	52084
@VP	were present at 42 days	52125
@VP	do	52577
@VP	might be required	52993
@VP	be required	52999
@VP	required	53002
@VP	could be associated with loss of behavioral gains and associated neurocircuitry	53027
@VP	be associated with loss of behavioral gains and associated neurocircuitry	53033
@VP	associated with loss of behavioral gains and associated neurocircuitry	53036
@VP	associated with loss of behavioral gains	53036
@VP	associated neurocircuitry	53081
@VP	is sufficient to engender a stable remodeling of neurocircuitry	53258
@VP	to engender a stable remodeling of neurocircuitry	53272
@VP	engender a stable remodeling of neurocircuitry	53275
@VP	are needed	53407
@VP	needed	53411
@VP	may limit their utility in long-term SCI experiments	53497
@VP	limit their utility in long-term SCI experiments	53501
@VP	was to study the animals for one year	53568
@VP	to study the animals for one year	53572
@VP	study the animals for one year	53575
@VP	persisted despite the use of chronic antibiotic therapy	53691
@VP	using nude rats	53798
@VP	was not encountered -LRB- Guest et al. , 1997a , b -RRB-	53827
@VP	encountered -LRB- Guest et al. , 1997a , b -RRB-	53835
@VP	is progressive renal damage	53949
@VP	appeared to weaken the animals	54011
@VP	to weaken the animals	54020
@VP	weaken the animals	54023
@VP	worsened induced pyelonephritis	54268
@VP	induced pyelonephritis	54277
@VP	lack a strong reaction to foreign tissue antigens	54320
@VP	have intact humoral immunity -LRB- Vos et al. , 1980 -RRB-	54384
@VP	have systemic immunosuppressive effects -LRB- Riegger et al. , 2007 -RRB- that	54456
@VP	compromised by abnormal urine clearance	54561
@VP	predispose to chronic urinary infection	54602
@VP	might adversely affect the outcome from therapeutic cell transplantation for SCI	54721
@VP	affect the outcome from therapeutic cell transplantation for SCI	54737
@VP	had unexpectedly high scores on the graded angle gridwalk	54966
@VP	graded angle gridwalk	55002
@VP	stepping by the control animals	55039
@VP	was unanticipated	55071
@VP	hind-limb stepping movements during ascent of the gridwalk	55105
@VP	were also frequent clonic spastic movements of the hind-limbs	55170
@VP	graded gridwalk	55237
@VP	to have contact	55421
@VP	have contact	55424
@VP	thereby increasing the pressure per unit surface area	55438
@VP	using an inclined gridwalk	55842
@VP	differ from those of Ramon-Cueto -LRB- Ramon-Cueto , 2000 -RRB-	55869
@VP	showed some effect of the transplantation	56088
@VP	did not occur	56144
@VP	occur	56152
@VP	distally regenerating CST fibers	56246
@VP	are not essential for recovery of weightsupported hind-limb locomotion	56279
@VP	influenced the collateralization of the CSTand the appearance of the terminals	56374
@VP	are consistent with those in which increased collateral formation	56949
@VP	increased collateral formation	56984
@VP	are consistent with a neurotrophic effect	57210
@VP	to produce levels of NT-3 close to those used in these exogenous applications	57462
@VP	produce levels of NT-3 close to those used in these exogenous applications	57465
@VP	used in these exogenous applications	57503
@VP	were essential to the observed recovery -LRB- Lu et al. , 2001 -RRB-	58288
@VP	correlated with the extent of open field	58402
@VP	was not lost when such fibers	58505
@VP	lost when such fibers	58513
@VP	crossing the transection	58551
@VP	affected the neurocircuitry within the isolated spinal cord segment	58623
@VP	permits their unequivocal identification	58713
@VP	transfected OEGs in nude rats	58823
@VP	was clearly distinct from Hoechst	58878
@VP	have transplanted OEG directly into or adjacent to lesion sites	59086
@VP	transplanted OEG directly into or adjacent to lesion sites	59091
@VP	transplanted OEG directly into	59091
@VP	adjacent to lesion sites	59125
@VP	differed	59512
@VP	were GFP negative	59569
@VP	were found in the spinal cord	59709
@VP	found in the spinal cord	59714
@VP	was also found within probable macrophages	59766
@VP	found within probable macrophages	59775
@VP	was an unreliable marker of transplanted OEGs in this study	59827
@VP	appear to be a superior compartment for survival of OEG	59900
@VP	to be a superior compartment for survival of OEG	59907
@VP	be a superior compartment for survival of OEG	59910
@VP	occur both rostral and caudal to the transection site	60222
@VP	affect locomotor activity	60280
@VP	were observed at the EM level	60338
@VP	observed at the EM level	60343
@VP	to support regeneration -LRB- Li et al. , 2005a , b ; Lipson et al. , 2003 -RRB-	60451
@VP	support regeneration -LRB- Li et al. , 2005a , b ; Lipson et al. , 2003 -RRB-	60454
@VP	have been shown to both support axonal growth	60522
@VP	been shown to both support axonal growth	60527
@VP	shown to both support axonal growth	60532
@VP	were observed in two patterns	60736
@VP	observed in two patterns	60741
@VP	ensheathing axons	60787
@VP	having cytoplasmic contacts with astrocytes in the absence of perineurial cells	60809
@VP	surrounding unmyelinated axons	60934
@VP	had direct contact with astrocyte processes in the injury region	61030
@VP	Establishing direct astrocyte contacts without intervening basal lamina	61096
@VP	intervening basal lamina	61143
@VP	hypothesized for transplanted OEG	61177
@VP	previously demonstrated	61220
@VP	are transplanted into the injured spinal cord -LRB- unpublished data -RRB-	61272
@VP	transplanted into the injured spinal cord -LRB- unpublished data -RRB-	61276
@VP	can occur when OEG ensheath but not if they myelinate	61415
@VP	occur when OEG ensheath but not if they myelinate	61419
@VP	myelinate	61459
@VP	precluding direct contact with astrocytes	61590
@VP	not seen in comparable regions of control-injected spinal cords	61767
@VP	found within astrocytic parenchyma weremyelinating	62022
@VP	argues against their being in-migrating endogenous Schwann cells	62073
@VP	being in-migrating endogenous Schwann cells	62094
@VP	means that they are unlikely to be apoptotic dying cells	62180
@VP	are unlikely to be apoptotic dying cells	62196
@VP	to be apoptotic dying cells	62209
@VP	be apoptotic dying cells	62212
@VP	are not known to form punctate adhesions with astrocytes	62303
@VP	known to form punctate adhesions with astrocytes	62311
@VP	to form punctate adhesions with astrocytes	62317
@VP	form punctate adhesions with astrocytes	62320
@VP	are FB known to ensheath axons	62364
@VP	spatially separated from astrocytes by considerable basal lamina and collagen	62436
@VP	may represent transplanted OEG interacting with host astrocytes	62533
@VP	represent transplanted OEG interacting with host astrocytes	62537
@VP	transplanted OEG interacting with host astrocytes	62547
@VP	interacting with host astrocytes	62564
@VP	were organized into fascicles	62662
@VP	organized into fascicles	62667
@VP	surrounded by perineurial-like cells	62692
@VP	to be a type of ensheathing cell	62905
@VP	be a type of ensheathing cell	62908
@VP	lacked dark cytoplasm	62961
@VP	ensheathed several axons	63052
@VP	were also observed in the injury area from control animals	63292
@VP	observed in the injury area from control animals	63302
@VP	lacked cells with dark cytoplasm	63360
@VP	ensheathed axons either within or outside of perineuria in distinct patterns	63440
@VP	did not myelinate	63546
@VP	performed myelination within the same fascicle	63905
@VP	might represent another capability in the plastic repertoire of ensheathing glia	63958
@VP	represent another capability in the plastic repertoire of ensheathing glia	63964
